SALL1 (spalt like transcription factor 1) - Rat Genome Database

Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Pathways
Gene: SALL1 (spalt like transcription factor 1) Homo sapiens
Analyze
Symbol: SALL1
Name: spalt like transcription factor 1
RGD ID: 1320515
HGNC Page HGNC:10524
Description: Enables beta-catenin binding activity. Involved in several processes, including endocrine system development; olfactory bulb mitral cell layer development; and regulation of transcription by RNA polymerase II. Located in several cellular components, including chromocenter; heterochromatin; and nucleus. Implicated in Townes-Brocks syndrome; middle lobe syndrome; and renal Wilms' tumor. Biomarker of chronic kidney disease and hepatoblastoma.
Type: protein-coding
RefSeq Status: REVIEWED
Previously known as: epididymis secretory protein Li 89; HEL-S-89; HSAL1; Sal-1; sal-like protein 1; spalt-like transcription factor 1; TBS; zinc finger protein 794; zinc finger protein SALL1; zinc finger protein Spalt-1; ZNF794
RGD Orthologs
Mouse
Rat
Chinchilla
Bonobo
Dog
Squirrel
Pig
Green Monkey
Naked Mole-Rat
Alliance Genes
More Info more info ...
Related Pseudogenes: SALL1P1  
Allele / Splice: See ClinVar data
Latest Assembly: GRCh38 - Human Genome Assembly GRCh38
Position:
Human AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCh381651,135,982 - 51,152,334 (-)NCBIGRCh38GRCh38hg38GRCh38
GRCh38.p13 Ensembl1651,135,982 - 51,152,334 (-)EnsemblGRCh38hg38GRCh38
GRCh371651,169,893 - 51,185,181 (-)NCBIGRCh37GRCh37hg19GRCh37
Build 361649,727,387 - 49,742,684 (-)NCBINCBI36Build 36hg18NCBI36
Build 341649,727,829 - 49,742,653NCBI
Celera1635,686,254 - 35,701,557 (-)NCBICelera
Cytogenetic Map16q12.1NCBI
HuRef1637,057,983 - 37,073,288 (-)NCBIHuRef
CHM1_11652,577,216 - 52,592,517 (-)NCBICHM1_1
T2T-CHM13v2.01656,933,839 - 56,950,190 (-)NCBIT2T-CHM13v2.0
JBrowse: View Region in Genome Browser (JBrowse)
Model


Gene-Chemical Interaction Annotations     Click to see Annotation Detail View
(1->4)-beta-D-glucan  (ISO)
1,2-dimethylhydrazine  (ISO)
17beta-estradiol  (EXP)
2,3,7,8-tetrachlorodibenzodioxine  (ISO)
2,4-dinitrotoluene  (ISO)
2,6-dinitrotoluene  (ISO)
4,4'-diaminodiphenylmethane  (ISO)
4,4'-sulfonyldiphenol  (EXP)
4-hydroxyphenyl retinamide  (ISO)
5-aza-2'-deoxycytidine  (EXP)
6-propyl-2-thiouracil  (ISO)
acrylamide  (EXP)
aflatoxin B1  (EXP)
aristolochic acid A  (EXP)
arsenite(3-)  (EXP)
azathioprine  (EXP)
benzo[a]pyrene  (EXP)
benzo[a]pyrene diol epoxide I  (EXP)
bis(2-ethylhexyl) phthalate  (EXP)
bisphenol A  (EXP,ISO)
buspirone  (ISO)
cadmium dichloride  (ISO)
caffeine  (EXP)
carbamazepine  (EXP)
choline  (ISO)
clobetasol  (ISO)
copper atom  (ISO)
copper(0)  (ISO)
copper(II) sulfate  (EXP)
cyclophosphamide  (EXP)
cyclosporin A  (EXP)
dichloromethane  (ISO)
dicrotophos  (EXP)
dieldrin  (ISO)
dorsomorphin  (EXP)
ethanol  (ISO)
flutamide  (ISO)
folic acid  (ISO)
fonofos  (EXP)
fulvestrant  (EXP)
furan  (ISO)
genistein  (EXP)
indometacin  (EXP)
inulin  (ISO)
L-methionine  (ISO)
lipopolysaccharide  (EXP)
metformin  (ISO)
methapyrilene  (ISO)
methylmercury chloride  (EXP)
nefazodone  (ISO)
paracetamol  (EXP)
parathion  (EXP)
perfluorooctane-1-sulfonic acid  (ISO)
phenobarbital  (ISO)
phenylmercury acetate  (EXP)
quercetin  (EXP)
raloxifene  (EXP)
rotenone  (EXP)
S-(1,2-dichlorovinyl)-L-cysteine  (EXP)
SB 431542  (EXP)
sodium arsenite  (EXP)
tamoxifen  (EXP,ISO)
terbufos  (EXP)
tetrachloromethane  (ISO)
thioacetamide  (ISO)
titanium dioxide  (ISO)
trichloroethene  (ISO)
trichostatin A  (EXP)
triclosan  (EXP)
triphenyl phosphate  (ISO)
tris(2-butoxyethyl) phosphate  (EXP)
urethane  (EXP)
valproic acid  (EXP,ISO)
venlafaxine hydrochloride  (EXP)
vinclozolin  (ISO)
zinc atom  (ISO)
zinc dichloride  (ISO)
zinc(0)  (ISO)

Gene Ontology Annotations     Click to see Annotation Detail View

Biological Process
adrenal gland development  (IEP)
branching involved in ureteric bud morphogenesis  (ISO,ISS)
embryonic digestive tract development  (IMP)
embryonic digit morphogenesis  (IMP)
forelimb morphogenesis  (ISO)
GABAergic neuron differentiation  (ISO)
gonad development  (IEP)
heart development  (IMP)
hindlimb morphogenesis  (ISO)
inductive cell-cell signaling  (ISO,ISS)
kidney development  (IMP)
kidney epithelium development  (ISS)
limb development  (IMP)
mesenchymal stem cell maintenance involved in metanephric nephron morphogenesis  (ISO)
mesenchymal to epithelial transition involved in metanephros morphogenesis  (IEP,ISO)
negative regulation of DNA-templated transcription  (IDA)
negative regulation of ectoderm development  (ISO)
negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis  (ISO)
negative regulation of mesoderm development  (ISO)
negative regulation of smoothened signaling pathway  (ISO)
negative regulation of transcription by RNA polymerase II  (IDA,IEA,ISO)
neural tube closure  (ISO)
neural tube development  (ISO)
neuron differentiation  (ISO)
olfactory bulb development  (ISO)
olfactory bulb interneuron differentiation  (ISS)
olfactory bulb mitral cell layer development  (IMP)
olfactory nerve development  (ISO,ISS)
pituitary gland development  (IEP)
positive regulation of branching involved in ureteric bud morphogenesis  (ISO)
positive regulation of DNA-templated transcription  (IDA)
positive regulation of neuron differentiation  (ISO)
positive regulation of transcription by RNA polymerase II  (IDA,ISO)
positive regulation of Wnt signaling pathway  (IDA)
regulation of neuroblast proliferation  (ISO)
regulation of transcription by RNA polymerase II  (IBA)
smoothened signaling pathway  (ISO)
transcription by RNA polymerase II  (ISO)
ureteric bud development  (ISO,ISS)
ureteric bud invasion  (ISO,ISS)
ventricular septum development  (ISO,ISS)

Cellular Component
chromocenter  (IDA)
cytoplasm  (IDA)
heterochromatin  (IDA)
nucleoplasm  (TAS)
nucleus  (IBA,IDA,IEA)
NuRD complex  (ISO)

Phenotype Annotations     Click to see Annotation Detail View

Human Phenotype
1-2 toe syndactyly  (IAGP)
2-3 toe syndactyly  (IAGP)
2-4 finger syndactyly  (IAGP)
3-4 finger syndactyly  (IAGP)
3-4 toe syndactyly  (IAGP)
4-5 toe syndactyly  (IAGP)
Abnormal cardiac septum morphology  (IAGP)
Abnormal foot morphology  (IAGP)
Abnormal pulmonary valve morphology  (IAGP)
Abnormal rib morphology  (IAGP)
Abnormal tragus morphology  (IAGP)
Abnormal vagina morphology  (IAGP)
Abnormal vertebral morphology  (IAGP)
Abnormality of cardiovascular system morphology  (IAGP)
Abnormality of the kidney  (IAGP)
Abnormality of the uterus  (IAGP)
Abnormality of vision  (IAGP)
Absent toe  (IAGP)
Agenesis of corpus callosum  (IAGP)
Anal atresia  (IAGP)
Anal stenosis  (IAGP)
Anteriorly placed anus  (IAGP)
Aplasia/Hypoplasia of the 3rd toe  (IAGP)
Atrial septal defect  (IAGP)
Autosomal dominant inheritance  (IAGP)
Bifid scrotum  (IAGP)
Bifid uterus  (IAGP)
Blepharophimosis  (IAGP)
Bowel incontinence  (IAGP)
Broad hallux phalanx  (IAGP)
Broad thumb  (IAGP)
Cataract  (IAGP)
Chiari malformation  (IAGP)
Choanal atresia  (IAGP)
Chorioretinal coloboma  (IAGP)
Clinodactyly of the 5th finger  (IAGP)
Clinodactyly of the 5th toe  (IAGP)
Congenital onset  (IAGP)
Constipation  (IAGP)
Cranial nerve paralysis  (IAGP)
Cryptorchidism  (IAGP)
Delayed puberty  (IAGP)
Duane anomaly  (IAGP)
Duodenal atresia  (IAGP)
Ectopic kidney  (IAGP)
External ear malformation  (IAGP)
Facial asymmetry  (IAGP)
Failure to thrive  (IAGP)
Gastroesophageal reflux  (IAGP)
Global developmental delay  (IAGP)
Hearing impairment  (IAGP)
Holoprosencephaly  (IAGP)
Hydrocephalus  (IAGP)
Hypoplasia of penis  (IAGP)
Hypospadias  (IAGP)
Hypothyroidism  (IAGP)
Intellectual disability  (IAGP)
Iris coloboma  (IAGP)
Limbal dermoid  (IAGP)
Lop ear  (IAGP)
Lower limb asymmetry  (IAGP)
Macrotia  (IAGP)
Metatarsal synostosis  (IAGP)
Microcephaly  (IAGP)
Microphthalmia  (IAGP)
Microtia  (IAGP)
Multicystic kidney dysplasia  (IAGP)
Multiple renal cysts  (IAGP)
Overfolded helix  (IAGP)
Overfolding of the superior helices  (IAGP)
Partial duplication of thumb phalanx  (IAGP)
Patent ductus arteriosus  (IAGP)
Pes planus  (IAGP)
Preauricular pit  (IAGP)
Preauricular skin tag  (IAGP)
Preaxial hand polydactyly  (IAGP)
Pseudoepiphyses of second metacarpal  (IAGP)
Rectoperineal fistula  (IAGP)
Rectovaginal fistula  (IAGP)
Renal dysplasia  (IAGP)
Renal hypoplasia  (IAGP)
Renal insufficiency  (IAGP)
Satyr ear  (IAGP)
Sensorineural hearing impairment  (IAGP)
Short metatarsal  (IAGP)
Short stature  (IAGP)
Small for gestational age  (IAGP)
Stahl ear  (IAGP)
Strabismus  (IAGP)
Subcutaneous nodule  (IAGP)
Talipes  (IAGP)
Tethered cord  (IAGP)
Tetralogy of Fallot  (IAGP)
Toe clinodactyly  (IAGP)
Toe syndactyly  (IAGP)
Tracheoesophageal fistula  (IAGP)
Triphalangeal thumb  (IAGP)
Ulnar deviation of finger  (IAGP)
Umbilical hernia  (IAGP)
Urethral valve  (IAGP)
Ventricular septal defect  (IAGP)
Vesicoureteral reflux  (IAGP)
Wide mouth  (IAGP)
References

References - curated
# Reference Title Reference Citation
1. SALL1 mutation analysis in Townes-Brocks syndrome: twelve novel mutations and expansion of the phenotype. Botzenhart EM, etal., Hum Mutat. 2005 Sep;26(3):282.
2. SALL4 is a marker of the embryonal subtype of hepatoblastoma. Gnemmi V, etal., Histopathology. 2013 Sep;63(3):425-8. doi: 10.1111/his.12187. Epub 2013 Jul 3.
3. GOAs Human GO annotations GOA_HUMAN data from the GO Consortium
4. SALL1 mutations in Townes-Brocks syndrome and related disorders. Kohlhase J Hum Mutat. 2000 Dec;16(6):460-6.
5. Accumulation of malignant renal stem cells is associated with epigenetic changes in normal renal progenitor genes. Metsuyanim S, etal., Stem Cells. 2008 Jul;26(7):1808-17. doi: 10.1634/stemcells.2007-0322. Epub 2008 May 8.
6. Murine homolog of SALL1 is essential for ureteric bud invasion in kidney development. Nishinakamura R, etal., Development. 2001 Aug;128(16):3105-15. doi: 10.1242/dev.128.16.3105.
7. OMIM Disease Annotation Pipeline OMIM Disease Annotation Pipeline
8. ClinVar Automated Import and Annotation Pipeline RGD automated import pipeline for ClinVar variants, variant-to-disease annotations and gene-to-disease annotations
9. Data Import for Chemical-Gene Interactions RGD automated import pipeline for gene-chemical interactions
10. RGD HPO Phenotype Annotation Pipeline RGD automated import pipeline for human HPO-to-gene-to-disease annotations
11. Therapeutic potential of human induced pluripotent stem cells and renal progenitor cells in experimental chronic kidney disease. Ribeiro PC, etal., Stem Cell Res Ther. 2020 Dec 9;11(1):530. doi: 10.1186/s13287-020-02060-4.
Additional References at PubMed
PMID:8975705   PMID:9425907   PMID:9973281   PMID:10533063   PMID:10928856   PMID:10965108   PMID:11484202   PMID:11511981   PMID:11751684   PMID:11836251   PMID:12065233   PMID:12200128  
PMID:12395297   PMID:12477932   PMID:15158448   PMID:15342556   PMID:16221172   PMID:16344560   PMID:16429401   PMID:16443351   PMID:16545361   PMID:16670092   PMID:16971658   PMID:17426652  
PMID:17910067   PMID:18000979   PMID:18024993   PMID:18280297   PMID:18297069   PMID:18470945   PMID:19005989   PMID:19213029   PMID:19247946   PMID:19274049   PMID:19440552   PMID:19942929  
PMID:20301618   PMID:20548946   PMID:20634891   PMID:21062744   PMID:21300955   PMID:21532573   PMID:21873635   PMID:22308078   PMID:22504420   PMID:23069192   PMID:23643386   PMID:24165912  
PMID:24292671   PMID:25241763   PMID:25609649   PMID:26186194   PMID:26687479   PMID:28514442   PMID:29395067   PMID:29395072   PMID:29507755   PMID:29625565   PMID:29844126   PMID:30385546  
PMID:31040265   PMID:31182584   PMID:32296183   PMID:32694731   PMID:33098486   PMID:33961781   PMID:34079125   PMID:34257535   PMID:34709266   PMID:34780483   PMID:34795231   PMID:35044719  
PMID:35140242   PMID:35182466   PMID:35271311   PMID:36252910   PMID:36833185  


Genomics

Comparative Map Data
SALL1
(Homo sapiens - human)
Human AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCh381651,135,982 - 51,152,334 (-)NCBIGRCh38GRCh38hg38GRCh38
GRCh38.p13 Ensembl1651,135,982 - 51,152,334 (-)EnsemblGRCh38hg38GRCh38
GRCh371651,169,893 - 51,185,181 (-)NCBIGRCh37GRCh37hg19GRCh37
Build 361649,727,387 - 49,742,684 (-)NCBINCBI36Build 36hg18NCBI36
Build 341649,727,829 - 49,742,653NCBI
Celera1635,686,254 - 35,701,557 (-)NCBICelera
Cytogenetic Map16q12.1NCBI
HuRef1637,057,983 - 37,073,288 (-)NCBIHuRef
CHM1_11652,577,216 - 52,592,517 (-)NCBICHM1_1
T2T-CHM13v2.01656,933,839 - 56,950,190 (-)NCBIT2T-CHM13v2.0
Sall1
(Mus musculus - house mouse)
Mouse AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCm39889,753,867 - 89,770,790 (-)NCBIGRCm39GRCm39mm39
GRCm39 Ensembl889,753,863 - 89,770,790 (-)EnsemblGRCm39 Ensembl
GRCm38889,027,242 - 89,044,162 (-)NCBIGRCm38GRCm38mm10GRCm38
GRCm38.p6 Ensembl889,027,235 - 89,044,162 (-)EnsemblGRCm38mm10GRCm38
MGSCv37891,551,141 - 91,568,061 (-)NCBIGRCm37MGSCv37mm9NCBIm37
MGSCv36891,918,348 - 91,932,544 (-)NCBIMGSCv36mm8
Celera893,321,670 - 93,338,514 (-)NCBICelera
Cytogenetic Map8C3NCBI
Sall1
(Rattus norvegicus - Norway rat)
Rat AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
mRatBN7.21918,005,782 - 18,022,705 (+)NCBImRatBN7.2mRatBN7.2
mRatBN7.2 Ensembl1918,007,503 - 18,022,705 (+)EnsemblmRatBN7.2 Ensembl
UTH_Rnor_SHR_Utx1919,687,226 - 19,702,424 (+)NCBIRnor_SHR
UTH_Rnor_SHRSP_BbbUtx_1.01924,881,820 - 24,897,018 (+)NCBIRnor_SHRSP
UTH_Rnor_WKY_Bbb_1.01927,838,998 - 27,854,185 (+)NCBIRnor_WKY
Rnor_6.01923,387,737 - 23,405,025 (+)NCBIRnor6.0Rnor_6.0rn6Rnor6.0
Rnor_6.0 Ensembl1923,389,375 - 23,405,039 (+)EnsemblRnor6.0rn6Rnor6.0
Rnor_5.01934,377,838 - 34,395,131 (+)NCBIRnor5.0Rnor_5.0rn5Rnor5.0
RGSC_v3.41919,277,337 - 19,293,298 (+)NCBIRGSC3.4RGSC_v3.4rn4RGSC3.4
RGSC_v3.11919,283,733 - 19,298,618 (+)NCBI
Celera1917,896,753 - 17,911,869 (+)NCBICelera
Cytogenetic Map19p11NCBI
Sall1
(Chinchilla lanigera - long-tailed chinchilla)
Chinchilla AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
ChiLan1.0 EnsemblNW_0049554339,144,748 - 9,161,171 (-)EnsemblChiLan1.0
ChiLan1.0NW_0049554339,146,074 - 9,161,171 (-)NCBIChiLan1.0ChiLan1.0
SALL1
(Pan paniscus - bonobo/pygmy chimpanzee)
Bonobo AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
NHGRI_mPanPan11666,506,188 - 66,522,403 (-)NCBINHGRI_mPanPan1
Mhudiblu_PPA_v01631,396,399 - 31,412,753 (-)NCBIMhudiblu_PPA_v0Mhudiblu_PPA_v0panPan3
PanPan1.11650,274,081 - 50,280,239 (-)NCBIpanpan1.1PanPan1.1panPan2
PanPan1.1 Ensembl1650,274,090 - 50,284,819 (-)Ensemblpanpan1.1panPan2
SALL1
(Canis lupus familiaris - dog)
Dog AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
CanFam3.1264,242,742 - 64,260,021 (+)NCBICanFam3.1CanFam3.1canFam3CanFam3.1
CanFam3.1 Ensembl264,243,987 - 64,259,521 (+)EnsemblCanFam3.1canFam3CanFam3.1
Dog10K_Boxer_Tasha260,816,127 - 60,833,504 (+)NCBIDog10K_Boxer_Tasha
ROS_Cfam_1.0264,787,008 - 64,804,401 (+)NCBIROS_Cfam_1.0
ROS_Cfam_1.0 Ensembl264,787,375 - 64,804,352 (+)EnsemblROS_Cfam_1.0 Ensembl
UMICH_Zoey_3.1261,612,959 - 61,630,321 (+)NCBIUMICH_Zoey_3.1
UNSW_CanFamBas_1.0262,631,291 - 62,648,633 (+)NCBIUNSW_CanFamBas_1.0
UU_Cfam_GSD_1.0263,519,257 - 63,536,638 (+)NCBIUU_Cfam_GSD_1.0
Sall1
(Ictidomys tridecemlineatus - thirteen-lined ground squirrel)
Squirrel AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
HiC_Itri_2NW_02440934955,465,986 - 55,483,143 (+)NCBIHiC_Itri_2
SpeTri2.0 EnsemblNW_0049364754,106,084 - 4,121,413 (-)EnsemblSpeTri2.0
SpeTri2.0NW_0049364754,106,663 - 4,121,356 (-)NCBISpeTri2.0SpeTri2.0SpeTri2.0
SALL1
(Sus scrofa - pig)
Pig AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
Sscrofa11.1 Ensembl633,732,025 - 33,748,704 (+)EnsemblSscrofa11.1susScr11Sscrofa11.1
Sscrofa11.1633,731,666 - 33,748,698 (+)NCBISscrofa11.1Sscrofa11.1susScr11Sscrofa11.1
Sscrofa10.2630,222,502 - 30,239,229 (+)NCBISscrofa10.2Sscrofa10.2susScr3
SALL1
(Chlorocebus sabaeus - green monkey)
Green Monkey AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
ChlSab1.1536,928,711 - 36,944,158 (-)NCBIChlSab1.1ChlSab1.1chlSab2
ChlSab1.1 Ensembl536,927,990 - 36,943,630 (-)EnsemblChlSab1.1ChlSab1.1 EnsemblchlSab2
Vero_WHO_p1.0NW_02366604739,548,229 - 39,564,556 (+)NCBIVero_WHO_p1.0Vero_WHO_p1.0
Sall1
(Heterocephalus glaber - naked mole-rat)
Naked Mole-Rat AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
HetGla_female_1.0 EnsemblNW_0046247575,572,528 - 5,587,617 (+)EnsemblHetGla_female_1.0HetGla_female_1.0 EnsemblhetGla2
HetGla 1.0NW_0046247575,572,510 - 5,587,623 (+)NCBIHetGla_female_1.0HetGla 1.0hetGla2

Variants

.
Variants in SALL1
346 total Variants

Clinical Variants
Name Type Condition(s) Position(s) Clinical significance
NM_002968.3(SALL1):c.1214dup (p.Leu406fs) duplication Townes syndrome [RCV000548925] Chr16:51141007..51141008 [GRCh38]
Chr16:51174918..51174919 [GRCh37]
Chr16:16q12.1
pathogenic
NM_002968.3(SALL1):c.1270del (p.Gln424fs) deletion Townes-Brocks syndrome 1 [RCV000007851] Chr16:51140952 [GRCh38]
Chr16:51174863 [GRCh37]
Chr16:16q12.1
pathogenic
NM_002968.3(SALL1):c.1115C>A (p.Ser372Ter) single nucleotide variant Townes-Brocks syndrome 1 [RCV000007852] Chr16:51141107 [GRCh38]
Chr16:51175018 [GRCh37]
Chr16:16q12.1
pathogenic
NM_002968.3(SALL1):c.826C>T (p.Arg276Ter) single nucleotide variant Townes syndrome [RCV000792529]|Townes-Brocks syndrome 1 [RCV000007853]|not provided [RCV003221781] Chr16:51141396 [GRCh38]
Chr16:51175307 [GRCh37]
Chr16:16q12.1
pathogenic
NM_002968.3(SALL1):c.1115C>G (p.Ser372Ter) single nucleotide variant Townes-Brocks syndrome 1 [RCV000007854] Chr16:51141107 [GRCh38]
Chr16:51175018 [GRCh37]
Chr16:16q12.1
pathogenic
NM_002968.3(SALL1):c.1277_1278del (p.Arg426fs) deletion Townes-Brocks syndrome 1 [RCV000007855] Chr16:51140944..51140945 [GRCh38]
Chr16:51174855..51174856 [GRCh37]
Chr16:16q12.1
pathogenic
NM_002968.3(SALL1):c.1347_1348del (p.His449fs) microsatellite Townes-Brocks syndrome 1 [RCV000007856] Chr16:51140874..51140875 [GRCh38]
Chr16:51174785..51174786 [GRCh37]
Chr16:16q12.1
pathogenic
NM_002968.3(SALL1):c.1821del (p.Leu608fs) deletion Townes-Brocks-branchiootorenal-like syndrome [RCV000007857] Chr16:51140401 [GRCh38]
Chr16:51174312 [GRCh37]
Chr16:16q12.1
pathogenic
NM_002968.3(SALL1):c.792_793del (p.Leu264fs) deletion Townes-Brocks syndrome 1 [RCV000007858] Chr16:51141429..51141430 [GRCh38]
Chr16:51175340..51175341 [GRCh37]
Chr16:16q12.1
pathogenic
NM_002968.3(SALL1):c.967C>T (p.Gln323Ter) single nucleotide variant Townes syndrome [RCV000697040]|Townes-Brocks syndrome 1 [RCV000989601]|Townes-Brocks-branchiootorenal-like syndrome [RCV000007859] Chr16:51141255 [GRCh38]
Chr16:51175166 [GRCh37]
Chr16:16q12.1
pathogenic
NM_002968.3(SALL1):c.1256T>A (p.Leu419Ter) single nucleotide variant Townes-Brocks syndrome 1 [RCV000007860] Chr16:51140966 [GRCh38]
Chr16:51174877 [GRCh37]
Chr16:16q12.1
pathogenic
NM_002968.3(SALL1):c.995del (p.Pro332fs) deletion Townes-Brocks syndrome 1 [RCV000007862] Chr16:51141227 [GRCh38]
Chr16:51175138 [GRCh37]
Chr16:16q12.1
pathogenic
SALL1, 2-BP DEL, 3414AT deletion Townes-Brocks syndrome 1 [RCV000007863] Chr16:16q12.1 pathogenic
NM_002968.3(SALL1):c.253_258del (p.Phe85_Ser86del) deletion not provided [RCV000722650] Chr16:51141964..51141969 [GRCh38]
Chr16:51175875..51175880 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.2(SALL1):c.466_477dup (p.Ser159_Gly160insSerSerSerSer) microsatellite Townes syndrome [RCV002533071]|not provided [RCV000723051]|not specified [RCV000730806] Chr16:51141744..51141745 [GRCh38]
Chr16:51175655..51175656 [GRCh37]
Chr16:16q12.1
benign|likely benign|uncertain significance
NM_002968.3(SALL1):c.2256del (p.Tyr753fs) deletion Townes syndrome [RCV000525061] Chr16:51139966 [GRCh38]
Chr16:51173877 [GRCh37]
Chr16:16q12.1
pathogenic
NM_002968.2(SALL1):c.*714A>G single nucleotide variant Lung cancer [RCV000099970] Chr16:51136398 [GRCh38]
Chr16:51170309 [GRCh37]
Chr16:16q12.1
uncertain significance
GRCh38/hg38 16q11.2-12.1(chr16:46466829-52314178)x3 copy number gain Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000052404]|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000052404]|See cases [RCV000052404] Chr16:46466829..52314178 [GRCh38]
Chr16:46500741..52348090 [GRCh37]
Chr16:45058242..50905591 [NCBI36]
Chr16:16q11.2-12.1
pathogenic
GRCh38/hg38 16q11.2-12.1(chr16:46466829-51939304)x1 copy number loss See cases [RCV000053309] Chr16:46466829..51939304 [GRCh38]
Chr16:46500741..51973216 [GRCh37]
Chr16:45058242..50530717 [NCBI36]
Chr16:16q11.2-12.1
pathogenic
GRCh38/hg38 16q11.2-12.1(chr16:46466829-51673196)x1 copy number loss See cases [RCV000053310] Chr16:46466829..51673196 [GRCh38]
Chr16:46500741..51707107 [GRCh37]
Chr16:45058242..50264608 [NCBI36]
Chr16:16q11.2-12.1
pathogenic
GRCh38/hg38 16q11.2-12.1(chr16:46471520-52405956)x1 copy number loss See cases [RCV000053328] Chr16:46471520..52405956 [GRCh38]
Chr16:46505432..52439868 [GRCh37]
Chr16:45062933..50997369 [NCBI36]
Chr16:16q11.2-12.1
pathogenic
GRCh38/hg38 16q12.1-12.2(chr16:47250644-54121476)x1 copy number loss See cases [RCV000053329] Chr16:47250644..54121476 [GRCh38]
Chr16:47284555..54155388 [GRCh37]
Chr16:45842056..52712889 [NCBI36]
Chr16:16q12.1-12.2
pathogenic
GRCh38/hg38 16q12.1(chr16:48156593-52220374)x1 copy number loss Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053330]|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053330]|See cases [RCV000053330] Chr16:48156593..52220374 [GRCh38]
Chr16:48190504..52254286 [GRCh37]
Chr16:46748005..50811787 [NCBI36]
Chr16:16q12.1
pathogenic
GRCh38/hg38 16q12.1(chr16:49740807-51876620)x1 copy number loss See cases [RCV000053331] Chr16:49740807..51876620 [GRCh38]
Chr16:49774718..51910531 [GRCh37]
Chr16:48332219..50468032 [NCBI36]
Chr16:16q12.1
pathogenic
GRCh38/hg38 16q12.1-12.2(chr16:50784329-55566715)x1 copy number loss See cases [RCV000053332] Chr16:50784329..55566715 [GRCh38]
Chr16:50818240..55600627 [GRCh37]
Chr16:49375741..54158128 [NCBI36]
Chr16:16q12.1-12.2
pathogenic
NM_002968.2(SALL1):c.3629C>T (p.Pro1210Leu) single nucleotide variant Malignant melanoma [RCV000071152] Chr16:51137458 [GRCh38]
Chr16:51171369 [GRCh37]
Chr16:49728870 [NCBI36]
Chr16:16q12.1
not provided
NM_002968.2(SALL1):c.3356C>T (p.Ser1119Phe) single nucleotide variant Malignant melanoma [RCV000071153] Chr16:51138866 [GRCh38]
Chr16:51172777 [GRCh37]
Chr16:49730278 [NCBI36]
Chr16:16q12.1
not provided
NM_002968.2(SALL1):c.2395C>T (p.Pro799Ser) single nucleotide variant Malignant melanoma [RCV000071154] Chr16:51139827 [GRCh38]
Chr16:51173738 [GRCh37]
Chr16:49731239 [NCBI36]
Chr16:16q12.1
not provided
NM_002968.2(SALL1):c.3674C>T (p.Ser1225Leu) single nucleotide variant Malignant melanoma [RCV000063055] Chr16:51137413 [GRCh38]
Chr16:51171324 [GRCh37]
Chr16:49728825 [NCBI36]
Chr16:16q12.1
not provided
NM_002968.2(SALL1):c.3239C>T (p.Ser1080Leu) single nucleotide variant Malignant melanoma [RCV000063056] Chr16:51138983 [GRCh38]
Chr16:51172894 [GRCh37]
Chr16:49730395 [NCBI36]
Chr16:16q12.1
not provided
NM_002968.2(SALL1):c.3116C>T (p.Ser1039Phe) single nucleotide variant Malignant melanoma [RCV000063057] Chr16:51139106 [GRCh38]
Chr16:51173017 [GRCh37]
Chr16:49730518 [NCBI36]
Chr16:16q12.1
not provided
NM_002968.2(SALL1):c.1015C>T (p.Pro339Ser) single nucleotide variant Malignant melanoma [RCV000063058] Chr16:51141207 [GRCh38]
Chr16:51175118 [GRCh37]
Chr16:49732619 [NCBI36]
Chr16:16q12.1
not provided
NM_002968.2(SALL1):c.624C>T (p.Ala208=) single nucleotide variant Malignant melanoma [RCV000063059] Chr16:51141598 [GRCh38]
Chr16:51175509 [GRCh37]
Chr16:49733010 [NCBI36]
Chr16:16q12.1
not provided
NM_002968.2(SALL1):c.477_478insAGC (p.Ser159_Gly160insSer) insertion not specified [RCV000175746] Chr16:51141744..51141745 [GRCh38]
Chr16:51175655..51175656 [GRCh37]
Chr16:16q12.1
likely benign
GRCh38/hg38 16q11.2-12.1(chr16:46466829-52422170)x1 copy number loss See cases [RCV000137306] Chr16:46466829..52422170 [GRCh38]
Chr16:46500741..52456082 [GRCh37]
Chr16:45058242..51013583 [NCBI36]
Chr16:16q11.2-12.1
pathogenic
GRCh38/hg38 16q11.2-12.1(chr16:46466829-52355793)x3 copy number gain See cases [RCV000137170] Chr16:46466829..52355793 [GRCh38]
Chr16:46500741..52389705 [GRCh37]
Chr16:45058242..50947206 [NCBI36]
Chr16:16q11.2-12.1
pathogenic
NM_002968.3(SALL1):c.3872A>G (p.Asn1291Ser) single nucleotide variant Townes syndrome [RCV000540322]|Townes-Brocks syndrome 1 [RCV000292562]|not provided [RCV000992805]|not specified [RCV000202832] Chr16:51137215 [GRCh38]
Chr16:51171126 [GRCh37]
Chr16:16q12.1
benign|likely benign|conflicting interpretations of pathogenicity
GRCh38/hg38 16q12.1-12.2(chr16:49570553-53467065)x1 copy number loss See cases [RCV000137722] Chr16:49570553..53467065 [GRCh38]
Chr16:49604464..53500977 [GRCh37]
Chr16:48161965..52058478 [NCBI36]
Chr16:16q12.1-12.2
pathogenic
NM_002968.3(SALL1):c.1878G>C (p.Glu626Asp) single nucleotide variant Townes syndrome [RCV000871312]|not provided [RCV001675668]|not specified [RCV000203210] Chr16:51140344 [GRCh38]
Chr16:51174255 [GRCh37]
Chr16:16q12.1
likely pathogenic|benign|likely benign
GRCh38/hg38 16q12.1-22.1(chr16:49685521-68401712)x3 copy number gain See cases [RCV000143752] Chr16:49685521..68401712 [GRCh38]
Chr16:49719432..68435615 [GRCh37]
Chr16:48276933..66993116 [NCBI36]
Chr16:16q12.1-22.1
pathogenic
NM_002968.3(SALL1):c.2549G>C (p.Ser850Thr) single nucleotide variant not provided [RCV000175741] Chr16:51139673 [GRCh38]
Chr16:51173584 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.448AGC[9] (p.Ser159del) microsatellite Townes syndrome [RCV001513382]|Townes-Brocks syndrome 1 [RCV000369147]|not provided [RCV001706124]|not specified [RCV000246493] Chr16:51141745..51141747 [GRCh38]
Chr16:51175656..51175658 [GRCh37]
Chr16:16q12.1
benign|conflicting interpretations of pathogenicity|uncertain significance
NM_002968.3(SALL1):c.1144A>G (p.Ser382Gly) single nucleotide variant not provided [RCV000175743] Chr16:51141078 [GRCh38]
Chr16:51174989 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.2283G>C (p.Pro761=) single nucleotide variant Townes-Brocks syndrome 1 [RCV002478568]|not provided [RCV000175744] Chr16:51139939 [GRCh38]
Chr16:51173850 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.3120A>G (p.Thr1040=) single nucleotide variant Townes syndrome [RCV000634155]|Townes-Brocks syndrome 1 [RCV002492750]|not provided [RCV001610487]|not specified [RCV000175745] Chr16:51139102 [GRCh38]
Chr16:51173013 [GRCh37]
Chr16:16q12.1
benign|likely benign|uncertain significance
NM_002968.3(SALL1):c.3794G>A (p.Gly1265Glu) single nucleotide variant Townes syndrome [RCV000870809]|Townes-Brocks syndrome 1 [RCV000387972]|not provided [RCV001711861]|not specified [RCV000348679] Chr16:51137293 [GRCh38]
Chr16:51171204 [GRCh37]
Chr16:16q12.1
benign|likely benign
NM_002968.3(SALL1):c.1322C>A (p.Thr441Asn) single nucleotide variant Inborn genetic diseases [RCV002519157]|not provided [RCV000864422]|not specified [RCV000301654] Chr16:51140900 [GRCh38]
Chr16:51174811 [GRCh37]
Chr16:16q12.1
benign|likely benign|uncertain significance
NM_002968.3(SALL1):c.809C>T (p.Pro270Leu) single nucleotide variant Townes syndrome [RCV001087010]|not provided [RCV000514663]|not specified [RCV000320758] Chr16:51141413 [GRCh38]
Chr16:51175324 [GRCh37]
Chr16:16q12.1
benign|likely benign
NM_002968.3(SALL1):c.448AGC[7] (p.Ser157_Ser159del) microsatellite Townes syndrome [RCV001413895]|Townes-Brocks syndrome 1 [RCV000269733]|not provided [RCV000871207]|not specified [RCV000322345] Chr16:51141745..51141753 [GRCh38]
Chr16:51175656..51175664 [GRCh37]
Chr16:16q12.1
benign|likely benign|conflicting interpretations of pathogenicity|uncertain significance
NM_002968.3(SALL1):c.235G>C (p.Ala79Pro) single nucleotide variant Townes syndrome [RCV002059139]|not provided [RCV001574061]|not specified [RCV000304067] Chr16:51141987 [GRCh38]
Chr16:51175898 [GRCh37]
Chr16:16q12.1
benign|likely benign
NM_002968.3(SALL1):c.3915C>T (p.Asn1305=) single nucleotide variant Townes syndrome [RCV000872592]|not provided [RCV001718582]|not specified [RCV000331240] Chr16:51137172 [GRCh38]
Chr16:51171083 [GRCh37]
Chr16:16q12.1
benign|likely benign|conflicting interpretations of pathogenicity
NM_002968.3(SALL1):c.949C>T (p.Pro317Ser) single nucleotide variant Townes-Brocks syndrome 1 [RCV000205374]|not provided [RCV002291589] Chr16:51141273 [GRCh38]
Chr16:51175184 [GRCh37]
Chr16:16q12.1
pathogenic|conflicting interpretations of pathogenicity|uncertain significance
NM_002968.3(SALL1):c.3160C>T (p.Arg1054Ter) single nucleotide variant Townes syndrome [RCV000634152]|Townes-Brocks syndrome 1 [RCV000203506]|not provided [RCV002305462] Chr16:51139062 [GRCh38]
Chr16:51172973 [GRCh37]
Chr16:16q12.1
pathogenic|likely pathogenic|uncertain significance|not provided
GRCh37/hg19 16q11.2-24.3(chr16:46615804-90142285)x1 copy number loss Ductal breast carcinoma [RCV000207138] Chr16:46615804..90142285 [GRCh37]
Chr16:16q11.2-24.3
uncertain significance
GRCh38/hg38 16q12.1-12.2(chr16:48543083-53879916)x1 copy number loss Ductal breast carcinoma [RCV000207292] Chr16:48543083..53879916 [GRCh38]
Chr16:48576994..53913828 [GRCh37]
Chr16:16q12.1-12.2
uncertain significance
NM_002968.3(SALL1):c.292A>G (p.Met98Val) single nucleotide variant Townes syndrome [RCV001088967]|not provided [RCV000224272]|not specified [RCV000246370] Chr16:51141930 [GRCh38]
Chr16:51175841 [GRCh37]
Chr16:16q12.1
benign
NM_002968.3(SALL1):c.814C>T (p.Gln272Ter) single nucleotide variant Townes syndrome [RCV001853841]|not provided [RCV000579178] Chr16:51141408 [GRCh38]
Chr16:51175319 [GRCh37]
Chr16:16q12.1
pathogenic
NM_002968.3(SALL1):c.3601G>A (p.Gly1201Ser) single nucleotide variant not provided [RCV000519326] Chr16:51137486 [GRCh38]
Chr16:51171397 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.2343G>C (p.Leu781=) single nucleotide variant Townes syndrome [RCV000549967]|not provided [RCV000712996]|not specified [RCV000246046] Chr16:51139879 [GRCh38]
Chr16:51173790 [GRCh37]
Chr16:16q12.1
benign
NM_002968.3(SALL1):c.478G>A (p.Gly160Ser) single nucleotide variant Townes syndrome [RCV001854962]|not provided [RCV001696194]|not specified [RCV000248435] Chr16:51141744 [GRCh38]
Chr16:51175655 [GRCh37]
Chr16:16q12.1
benign|likely benign|uncertain significance
NM_002968.3(SALL1):c.379G>C (p.Val127Leu) single nucleotide variant Townes syndrome [RCV001089030]|not provided [RCV000439131]|not specified [RCV000250871] Chr16:51141843 [GRCh38]
Chr16:51175754 [GRCh37]
Chr16:16q12.1
benign|likely benign|conflicting interpretations of pathogenicity
NM_002968.3(SALL1):c.2544A>G (p.Gln848=) single nucleotide variant Townes syndrome [RCV001088388]|not provided [RCV000525845]|not specified [RCV000250989] Chr16:51139678 [GRCh38]
Chr16:51173589 [GRCh37]
Chr16:16q12.1
benign|likely benign
NM_002968.3(SALL1):c.3199C>T (p.Leu1067Phe) single nucleotide variant Townes syndrome [RCV000550746]|Townes-Brocks syndrome 1 [RCV003139757] Chr16:51139023 [GRCh38]
Chr16:51172934 [GRCh37]
Chr16:16q12.1
likely benign|uncertain significance
NM_002968.3(SALL1):c.472A>G (p.Ser158Gly) single nucleotide variant Townes syndrome [RCV000865465]|not provided [RCV002274958]|not specified [RCV000244001] Chr16:51141750 [GRCh38]
Chr16:51175661 [GRCh37]
Chr16:16q12.1
benign|likely benign|conflicting interpretations of pathogenicity
NM_002968.3(SALL1):c.448AGC[11] (p.Ser159dup) microsatellite Townes syndrome [RCV000552954]|Townes-Brocks syndrome 1 [RCV000612233]|not provided [RCV001573351]|not specified [RCV000251431] Chr16:51141744..51141745 [GRCh38]
Chr16:51175655..51175656 [GRCh37]
Chr16:16q12.1
benign|likely benign|conflicting interpretations of pathogenicity
NM_002968.3(SALL1):c.478GGC[5] (p.Gly163dup) microsatellite Townes syndrome [RCV000533357]|Townes-Brocks syndrome 1 [RCV000356333]|not provided [RCV001711558]|not specified [RCV000254222] Chr16:51141732..51141733 [GRCh38]
Chr16:51175643..51175644 [GRCh37]
Chr16:16q12.1
benign|likely benign|conflicting interpretations of pathogenicity|uncertain significance
NM_002968.3(SALL1):c.3823G>A (p.Val1275Ile) single nucleotide variant Townes syndrome [RCV001520813]|Townes-Brocks syndrome 1 [RCV000349793]|not provided [RCV001640526]|not specified [RCV000242039] Chr16:51137264 [GRCh38]
Chr16:51171175 [GRCh37]
Chr16:16q12.1
benign
NM_002968.3(SALL1):c.76+26AC[5] microsatellite not provided [RCV001610634]|not specified [RCV000244594] Chr16:51151129..51151130 [GRCh38]
Chr16:51185040..51185041 [GRCh37]
Chr16:16q12.1
benign|likely benign
NM_002968.3(SALL1):c.390G>A (p.Pro130=) single nucleotide variant Townes syndrome [RCV001087416]|not provided [RCV000634154]|not specified [RCV000251993] Chr16:51141832 [GRCh38]
Chr16:51175743 [GRCh37]
Chr16:16q12.1
benign|likely benign
NM_002968.3(SALL1):c.1904C>T (p.Pro635Leu) single nucleotide variant Townes syndrome [RCV000864308]|not provided [RCV001711693]|not specified [RCV000244926] Chr16:51140318 [GRCh38]
Chr16:51174229 [GRCh37]
Chr16:16q12.1
benign|likely benign
NM_002968.3(SALL1):c.3456C>T (p.His1152=) single nucleotide variant Townes syndrome [RCV001510537]|Townes-Brocks syndrome 1 [RCV001795450]|not provided [RCV001711694]|not specified [RCV000242543] Chr16:51138766 [GRCh38]
Chr16:51172677 [GRCh37]
Chr16:16q12.1
benign
NM_002968.3(SALL1):c.3535-44CT[6] microsatellite not provided [RCV001610633]|not specified [RCV000247523] Chr16:51137583..51137584 [GRCh38]
Chr16:51171494..51171495 [GRCh37]
Chr16:16q12.1
benign|likely benign
NM_002968.3(SALL1):c.2574C>T (p.Leu858=) single nucleotide variant Townes syndrome [RCV001520814]|Townes-Brocks syndrome 1 [RCV000391169]|not provided [RCV001610632]|not specified [RCV000242992] Chr16:51139648 [GRCh38]
Chr16:51173559 [GRCh37]
Chr16:16q12.1
benign
NM_002968.3(SALL1):c.129C>T (p.His43=) single nucleotide variant Townes syndrome [RCV002518623]|not provided [RCV001711692]|not specified [RCV000252927] Chr16:51142093 [GRCh38]
Chr16:51176004 [GRCh37]
Chr16:16q12.1
benign|likely benign
NM_002968.3(SALL1):c.2967C>T (p.Leu989=) single nucleotide variant not specified [RCV000250570] Chr16:51139255 [GRCh38]
Chr16:51173166 [GRCh37]
Chr16:16q12.1
likely benign
NM_002968.3(SALL1):c.475A>G (p.Ser159Gly) single nucleotide variant Townes syndrome [RCV001515298]|Townes-Brocks syndrome 1 [RCV002272195]|not provided [RCV001709539]|not specified [RCV000243488] Chr16:51141747 [GRCh38]
Chr16:51175658 [GRCh37]
Chr16:16q12.1
benign
NM_002968.3(SALL1):c.2178G>A (p.Arg726=) single nucleotide variant Townes syndrome [RCV001516082]|not provided [RCV000992804]|not specified [RCV000248259] Chr16:51140044 [GRCh38]
Chr16:51173955 [GRCh37]
Chr16:16q12.1
benign|likely benign
NM_002968.3(SALL1):c.2310C>T (p.Ile770=) single nucleotide variant Townes syndrome [RCV000537361]|not provided [RCV001636773]|not specified [RCV000253246] Chr16:51139912 [GRCh38]
Chr16:51173823 [GRCh37]
Chr16:16q12.1
benign
NM_002968.2(SALL1):c.44A>C (p.Asp15Ala) single nucleotide variant Townes-Brocks syndrome 1 [RCV000283494] Chr16:51151198 [GRCh38]
Chr16:51185109 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.2(SALL1):c.*45C>A single nucleotide variant Townes-Brocks syndrome 1 [RCV000266009] Chr16:51137067 [GRCh38]
Chr16:51170978 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.3222G>A (p.Ala1074=) single nucleotide variant Townes syndrome [RCV000871349]|Townes-Brocks syndrome 1 [RCV002480143]|not provided [RCV001653564] Chr16:51139000 [GRCh38]
Chr16:51172911 [GRCh37]
Chr16:16q12.1
benign|likely benign
NM_002968.3(SALL1):c.220G>A (p.Val74Ile) single nucleotide variant Townes syndrome [RCV001464389]|not specified [RCV002248615] Chr16:51142002 [GRCh38]
Chr16:51175913 [GRCh37]
Chr16:16q12.1
likely benign|uncertain significance
NM_002968.2(SALL1):c.*922T>G single nucleotide variant Townes-Brocks syndrome 1 [RCV000287374] Chr16:51136190 [GRCh38]
Chr16:51170101 [GRCh37]
Chr16:16q12.1
likely benign
NM_002968.2(SALL1):c.*192T>C single nucleotide variant Townes-Brocks syndrome 1 [RCV000271928] Chr16:51136920 [GRCh38]
Chr16:51170831 [GRCh37]
Chr16:16q12.1
likely benign
NM_002968.3(SALL1):c.3942C>T (p.Phe1314=) single nucleotide variant Townes syndrome [RCV000872924]|Townes-Brocks syndrome 1 [RCV002504089]|not provided [RCV001690062]|not specified [RCV001820951] Chr16:51137145 [GRCh38]
Chr16:51171056 [GRCh37]
Chr16:16q12.1
benign|likely benign
NM_002968.2(SALL1):c.2557T>G (p.Ser853Ala) single nucleotide variant Townes-Brocks syndrome 1 [RCV000297267] Chr16:51139665 [GRCh38]
Chr16:51173576 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.2(SALL1):c.2399A>G (p.Asp800Gly) single nucleotide variant Townes-Brocks syndrome 1 [RCV000261863] Chr16:51139823 [GRCh38]
Chr16:51173734 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.537C>T (p.Leu179=) single nucleotide variant Townes syndrome [RCV002056497]|Townes-Brocks syndrome 1 [RCV002495011]|not provided [RCV000878015] Chr16:51141685 [GRCh38]
Chr16:51175596 [GRCh37]
Chr16:16q12.1
benign|likely benign
NM_002968.3(SALL1):c.351C>T (p.Asn117=) single nucleotide variant Townes syndrome [RCV000877917]|Townes-Brocks syndrome 1 [RCV002504090]|not provided [RCV001590950] Chr16:51141871 [GRCh38]
Chr16:51175782 [GRCh37]
Chr16:16q12.1
likely benign|uncertain significance
NM_002968.2(SALL1):c.3277G>A (p.Val1093Met) single nucleotide variant Townes-Brocks syndrome 1 [RCV000391161] Chr16:51138945 [GRCh38]
Chr16:51172856 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.2(SALL1):c.1006G>A (p.Gly336Ser) single nucleotide variant Townes-Brocks syndrome 1 [RCV000390281] Chr16:51141216 [GRCh38]
Chr16:51175127 [GRCh37]
Chr16:16q12.1
likely benign
NM_002968.2(SALL1):c.*1016T>C single nucleotide variant Townes-Brocks syndrome 1 [RCV000264916] Chr16:51136096 [GRCh38]
Chr16:51170007 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.3305A>G (p.Asp1102Gly) single nucleotide variant not provided [RCV000271174] Chr16:51138917 [GRCh38]
Chr16:51172828 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.*705_*706del deletion Townes-Brocks syndrome 1 [RCV000281493] Chr16:51136406..51136407 [GRCh38]
Chr16:51170317..51170318 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.676G>A (p.Val226Ile) single nucleotide variant not provided [RCV000513820] Chr16:51141546 [GRCh38]
Chr16:51175457 [GRCh37]
Chr16:16q12.1
likely benign
NM_002968.3(SALL1):c.3099_3105dup (p.Arg1036fs) duplication not provided [RCV000287226] Chr16:51139116..51139117 [GRCh38]
Chr16:51173027..51173028 [GRCh37]
Chr16:16q12.1
pathogenic
NM_002968.2(SALL1):c.*997C>A single nucleotide variant Townes-Brocks syndrome 1 [RCV000322324] Chr16:51136115 [GRCh38]
Chr16:51170026 [GRCh37]
Chr16:16q12.1
benign
NM_002968.3(SALL1):c.3947A>G (p.Glu1316Gly) single nucleotide variant Inborn genetic diseases [RCV002802575] Chr16:51137140 [GRCh38]
Chr16:51171051 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.1398C>A (p.Ile466=) single nucleotide variant Townes syndrome [RCV002055057]|not provided [RCV000272933] Chr16:51140824 [GRCh38]
Chr16:51174735 [GRCh37]
Chr16:16q12.1
likely benign|uncertain significance
NM_002968.3(SALL1):c.727C>T (p.Gln243Ter) single nucleotide variant not provided [RCV000302939] Chr16:51141495 [GRCh38]
Chr16:51175406 [GRCh37]
Chr16:16q12.1
pathogenic
NM_002968.2(SALL1):c.3768G>A (p.Gln1256=) single nucleotide variant Townes-Brocks syndrome 1 [RCV000296006] Chr16:51137319 [GRCh38]
Chr16:51171230 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.2825C>A (p.Pro942His) single nucleotide variant not provided [RCV001288382]|not specified [RCV000276120] Chr16:51139397 [GRCh38]
Chr16:51173308 [GRCh37]
Chr16:16q12.1
likely benign|uncertain significance
NM_002968.3(SALL1):c.1715C>T (p.Thr572Met) single nucleotide variant Townes syndrome [RCV002518098]|not provided [RCV000311105] Chr16:51140507 [GRCh38]
Chr16:51174418 [GRCh37]
Chr16:16q12.1
conflicting interpretations of pathogenicity|uncertain significance
NM_002968.2(SALL1):c.1731C>G (p.Pro577=) single nucleotide variant Townes-Brocks syndrome 1 [RCV000326701] Chr16:51140491 [GRCh38]
Chr16:51174402 [GRCh37]
Chr16:16q12.1
likely benign
NM_002968.3(SALL1):c.1903C>T (p.Pro635Ser) single nucleotide variant Townes syndrome [RCV003114449]|not provided [RCV001610780]|not specified [RCV000315235] Chr16:51140319 [GRCh38]
Chr16:51174230 [GRCh37]
Chr16:16q12.1
benign|likely benign
NM_002968.2(SALL1):c.*550G>T single nucleotide variant Townes-Brocks syndrome 1 [RCV000307202] Chr16:51136562 [GRCh38]
Chr16:51170473 [GRCh37]
Chr16:16q12.1
likely benign
NM_002968.2(SALL1):c.76+10C>G single nucleotide variant Townes syndrome [RCV002882266] Chr16:51151156 [GRCh38]
Chr16:51185067 [GRCh37]
Chr16:16q12.1
likely benign
NM_002968.2(SALL1):c.3711T>C (p.Tyr1237=) single nucleotide variant Townes-Brocks syndrome 1 [RCV000400930] Chr16:51137376 [GRCh38]
Chr16:51171287 [GRCh37]
Chr16:16q12.1
likely benign
NM_002968.2(SALL1):c.649G>A (p.Gly217Ser) single nucleotide variant Townes-Brocks syndrome 1 [RCV000401428] Chr16:51141573 [GRCh38]
Chr16:51175484 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.870_871dup (p.Gln291fs) microsatellite Townes syndrome [RCV001386756]|not provided [RCV000335508] Chr16:51141350..51141351 [GRCh38]
Chr16:51175261..51175262 [GRCh37]
Chr16:16q12.1
pathogenic
NM_002968.3(SALL1):c.*1112dup duplication Townes-Brocks syndrome 1 [RCV000327970] Chr16:51135999..51136000 [GRCh38]
Chr16:51169910..51169911 [GRCh37]
Chr16:16q12.1
likely benign
NM_002968.3(SALL1):c.477_478insAGCGGC (p.Ser159_Gly160insSerGly) insertion Townes syndrome [RCV003105844]|not provided [RCV000766499]|not specified [RCV000350628] Chr16:51141744..51141745 [GRCh38]
Chr16:51175655..51175656 [GRCh37]
Chr16:16q12.1
benign|likely benign|conflicting interpretations of pathogenicity|uncertain significance
NM_002968.3(SALL1):c.389C>T (p.Pro130Leu) single nucleotide variant Townes syndrome [RCV002976721] Chr16:51141833 [GRCh38]
Chr16:51175744 [GRCh37]
Chr16:16q12.1
likely benign
NM_002968.2(SALL1):c.3424A>G (p.Thr1142Ala) single nucleotide variant Townes-Brocks syndrome 1 [RCV000347610] Chr16:51138798 [GRCh38]
Chr16:51172709 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.2008T>C (p.Phe670Leu) single nucleotide variant not provided [RCV001680962] Chr16:51140214 [GRCh38]
Chr16:51174125 [GRCh37]
Chr16:16q12.1
benign|likely benign
NM_002968.3(SALL1):c.*920CTT[2] microsatellite Townes-Brocks syndrome 1 [RCV000379240]|not provided [RCV002510851] Chr16:51136184..51136186 [GRCh38]
Chr16:51170095..51170097 [GRCh37]
Chr16:16q12.1
benign|uncertain significance
NM_002968.2(SALL1):c.3947A>C (p.Glu1316Ala) single nucleotide variant Townes-Brocks syndrome 1 [RCV000380134] Chr16:51137140 [GRCh38]
Chr16:51171051 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.*1033dup duplication Townes-Brocks syndrome 1 [RCV000385156] Chr16:51136078..51136079 [GRCh38]
Chr16:51169989..51169990 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.1911G>A (p.Ala637=) single nucleotide variant Townes syndrome [RCV002521947]|not provided [RCV001610779]|not specified [RCV000287936] Chr16:51140311 [GRCh38]
Chr16:51174222 [GRCh37]
Chr16:16q12.1
benign|likely benign
NM_002968.3(SALL1):c.1329T>A (p.Asp443Glu) single nucleotide variant Townes-Brocks syndrome 1 [RCV002502147]|not provided [RCV000289286] Chr16:51140893 [GRCh38]
Chr16:51174804 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.*588del deletion Townes-Brocks syndrome 1 [RCV000312169] Chr16:51136524 [GRCh38]
Chr16:51170435 [GRCh37]
Chr16:16q12.1
benign
NM_002968.2(SALL1):c.*592G>A single nucleotide variant Townes-Brocks syndrome 1 [RCV000398604] Chr16:51136520 [GRCh38]
Chr16:51170431 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.*83GCCCC[1] microsatellite Townes-Brocks syndrome 1 [RCV000358349]|not provided [RCV001564068] Chr16:51137020..51137024 [GRCh38]
Chr16:51170931..51170935 [GRCh37]
Chr16:16q12.1
likely benign
NM_002968.2(SALL1):c.1502A>G (p.Glu501Gly) single nucleotide variant Townes-Brocks syndrome 1 [RCV000383660] Chr16:51140720 [GRCh38]
Chr16:51174631 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.2(SALL1):c.*558A>G single nucleotide variant Townes-Brocks syndrome 1 [RCV000408040] Chr16:51136554 [GRCh38]
Chr16:51170465 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.2(SALL1):c.*646C>T single nucleotide variant Townes-Brocks syndrome 1 [RCV000337827] Chr16:51136466 [GRCh38]
Chr16:51170377 [GRCh37]
Chr16:16q12.1
likely benign
NM_002968.2(SALL1):c.3929G>A (p.Arg1310His) single nucleotide variant Townes-Brocks syndrome 1 [RCV000317442] Chr16:51137158 [GRCh38]
Chr16:51171069 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.2(SALL1):c.263G>A (p.Ser88Asn) single nucleotide variant Townes-Brocks syndrome 1 [RCV000317519] Chr16:51141959 [GRCh38]
Chr16:51175870 [GRCh37]
Chr16:16q12.1
likely benign
NM_002968.3(SALL1):c.1025A>C (p.Asn342Thr) single nucleotide variant not provided [RCV000331820] Chr16:51141197 [GRCh38]
Chr16:51175108 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.484G>A (p.Gly162Ser) single nucleotide variant Townes syndrome [RCV002522015]|Townes-Brocks syndrome 1 [RCV002480049]|not provided [RCV000405577] Chr16:51141738 [GRCh38]
Chr16:51175649 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.2(SALL1):c.*437C>A single nucleotide variant Townes-Brocks syndrome 1 [RCV000364171] Chr16:51136675 [GRCh38]
Chr16:51170586 [GRCh37]
Chr16:16q12.1
likely benign
NM_002968.3(SALL1):c.986C>T (p.Thr329Ile) single nucleotide variant Inborn genetic diseases [RCV000624031]|not provided [RCV000334683] Chr16:51141236 [GRCh38]
Chr16:51175147 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.2373C>A (p.Gly791=) single nucleotide variant not provided [RCV000336180] Chr16:51139849 [GRCh38]
Chr16:51173760 [GRCh37]
Chr16:16q12.1
conflicting interpretations of pathogenicity|uncertain significance
NM_002968.3(SALL1):c.1108_1109del (p.Val370fs) deletion Townes-Brocks syndrome 1 [RCV000489064] Chr16:51141113..51141114 [GRCh38]
Chr16:51175024..51175025 [GRCh37]
Chr16:16q12.1
pathogenic
NM_002968.3(SALL1):c.1228G>T (p.Gly410Ter) single nucleotide variant Townes-Brocks syndrome 1 [RCV002283994] Chr16:51140994 [GRCh38]
Chr16:51174905 [GRCh37]
Chr16:16q12.1
pathogenic
NM_002968.3(SALL1):c.3938G>A (p.Arg1313His) single nucleotide variant Inborn genetic diseases [RCV002526035]|Townes syndrome [RCV001212454]|not provided [RCV000489514] Chr16:51137149 [GRCh38]
Chr16:51171060 [GRCh37]
Chr16:16q12.1
benign|uncertain significance
NM_002968.3(SALL1):c.3180C>A (p.Leu1060=) single nucleotide variant Townes syndrome [RCV002062026]|Townes-Brocks syndrome 1 [RCV002491189]|not specified [RCV000597625] Chr16:51139042 [GRCh38]
Chr16:51172953 [GRCh37]
Chr16:16q12.1
benign|likely benign
NM_002968.3(SALL1):c.2909T>C (p.Leu970Ser) single nucleotide variant not provided [RCV000723151] Chr16:51139313 [GRCh38]
Chr16:51173224 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.478GGC[3] (p.Gly163del) microsatellite not provided [RCV002292925] Chr16:51141733..51141735 [GRCh38]
Chr16:51175644..51175646 [GRCh37]
Chr16:16q12.1
likely benign
NM_002968.3(SALL1):c.43G>A (p.Asp15Asn) single nucleotide variant Townes-Brocks syndrome 1 [RCV000347818] Chr16:51151199 [GRCh38]
Chr16:51185110 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.2(SALL1):c.*904C>T single nucleotide variant Townes-Brocks syndrome 1 [RCV000335422] Chr16:51136208 [GRCh38]
Chr16:51170119 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.*563del deletion Townes-Brocks syndrome 1 [RCV000350691] Chr16:51136549 [GRCh38]
Chr16:51170460 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.448AGC[12] (p.Ser158_Ser159dup) microsatellite Townes syndrome [RCV000872954]|Townes-Brocks syndrome 1 [RCV000393511]|not provided [RCV001712032]|not specified [RCV000403758] Chr16:51141744..51141745 [GRCh38]
Chr16:51175655..51175656 [GRCh37]
Chr16:16q12.1
benign|uncertain significance
NM_002968.2(SALL1):c.*865A>C single nucleotide variant Townes-Brocks syndrome 1 [RCV000373606] Chr16:51136247 [GRCh38]
Chr16:51170158 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.2(SALL1):c.*125C>T single nucleotide variant Townes-Brocks syndrome 1 [RCV000310540] Chr16:51136987 [GRCh38]
Chr16:51170898 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.2(SALL1):c.1321A>G (p.Thr441Ala) single nucleotide variant Townes-Brocks syndrome 1 [RCV000339917] Chr16:51140901 [GRCh38]
Chr16:51174812 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.1016C>T (p.Pro339Leu) single nucleotide variant Townes-Brocks syndrome 1 [RCV002477945]|not provided [RCV001760677] Chr16:51141206 [GRCh38]
Chr16:51175117 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.2(SALL1):c.3713C>A (p.Ala1238Glu) single nucleotide variant Townes-Brocks syndrome 1 [RCV000344108] Chr16:51137374 [GRCh38]
Chr16:51171285 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.3750C>T (p.Asn1250=) single nucleotide variant Townes syndrome [RCV002531097]|not provided [RCV000592828] Chr16:51137337 [GRCh38]
Chr16:51171248 [GRCh37]
Chr16:16q12.1
likely benign|conflicting interpretations of pathogenicity|uncertain significance
NM_002968.3(SALL1):c.361A>G (p.Arg121Gly) single nucleotide variant Townes-Brocks syndrome 1 [RCV002506418]|not provided [RCV000593129] Chr16:51141861 [GRCh38]
Chr16:51175772 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.3021C>G (p.Gly1007=) single nucleotide variant not provided [RCV000591086] Chr16:51139201 [GRCh38]
Chr16:51173112 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.855A>G (p.Leu285=) single nucleotide variant Townes syndrome [RCV001493893] Chr16:51141367 [GRCh38]
Chr16:51175278 [GRCh37]
Chr16:16q12.1
likely benign
NM_002968.3(SALL1):c.411C>T (p.Ser137=) single nucleotide variant Townes syndrome [RCV001521920]|not provided [RCV000734381]|not specified [RCV001816807] Chr16:51141811 [GRCh38]
Chr16:51175722 [GRCh37]
Chr16:16q12.1
benign|likely benign|conflicting interpretations of pathogenicity|uncertain significance
NM_002968.3(SALL1):c.3270C>T (p.Asn1090=) single nucleotide variant Townes syndrome [RCV002536411]|not provided [RCV000728506] Chr16:51138952 [GRCh38]
Chr16:51172863 [GRCh37]
Chr16:16q12.1
likely benign|uncertain significance
NM_002968.3(SALL1):c.3222G>C (p.Ala1074=) single nucleotide variant not provided [RCV000728508] Chr16:51139000 [GRCh38]
Chr16:51172911 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.2223G>A (p.Arg741=) single nucleotide variant Townes syndrome [RCV003117527]|not provided [RCV000730177] Chr16:51139999 [GRCh38]
Chr16:51173910 [GRCh37]
Chr16:16q12.1
likely benign|uncertain significance
NM_002968.3(SALL1):c.175C>T (p.Leu59=) single nucleotide variant not provided [RCV000729023] Chr16:51142047 [GRCh38]
Chr16:51175958 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.2590G>A (p.Ala864Thr) single nucleotide variant not provided [RCV000733436] Chr16:51139632 [GRCh38]
Chr16:51173543 [GRCh37]
Chr16:16q12.1
conflicting interpretations of pathogenicity|uncertain significance
NM_002968.3(SALL1):c.3154C>T (p.Gln1052Ter) single nucleotide variant not provided [RCV000413349] Chr16:51139068 [GRCh38]
Chr16:51172979 [GRCh37]
Chr16:16q12.1
likely pathogenic
NM_002968.3(SALL1):c.1393C>T (p.Gln465Ter) single nucleotide variant not provided [RCV000414232] Chr16:51140829 [GRCh38]
Chr16:51174740 [GRCh37]
Chr16:16q12.1
pathogenic
NM_002968.3(SALL1):c.1763dup (p.Gly589fs) duplication not provided [RCV000414487] Chr16:51140458..51140459 [GRCh38]
Chr16:51174369..51174370 [GRCh37]
Chr16:16q12.1
pathogenic
GRCh37/hg19 16q11.2-24.3(chr16:46464488-90155062)x3 copy number gain See cases [RCV000446110] Chr16:46464488..90155062 [GRCh37]
Chr16:16q11.2-24.3
pathogenic
GRCh37/hg19 16p13.3-q24.3(chr16:69193-90274381)x3 copy number gain See cases [RCV000446684] Chr16:69193..90274381 [GRCh37]
Chr16:16p13.3-q24.3
pathogenic
NM_002968.3(SALL1):c.1950C>T (p.Gly650=) single nucleotide variant Townes syndrome [RCV001521068]|not provided [RCV000428044] Chr16:51140272 [GRCh38]
Chr16:51174183 [GRCh37]
Chr16:16q12.1
benign|likely benign
NM_002968.3(SALL1):c.3534+5C>T single nucleotide variant not specified [RCV000436189] Chr16:51138683 [GRCh38]
Chr16:51172594 [GRCh37]
Chr16:16q12.1
likely benign
NM_002968.3(SALL1):c.3157A>C (p.Met1053Leu) single nucleotide variant not provided [RCV000430109] Chr16:51139065 [GRCh38]
Chr16:51172976 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.3771C>T (p.Asn1257=) single nucleotide variant Townes syndrome [RCV002524840]|Townes-Brocks syndrome 1 [RCV002480291]|not specified [RCV000436838] Chr16:51137316 [GRCh38]
Chr16:51171227 [GRCh37]
Chr16:16q12.1
likely benign
NM_002968.3(SALL1):c.1405C>T (p.Arg469Cys) single nucleotide variant not provided [RCV000440800] Chr16:51140817 [GRCh38]
Chr16:51174728 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.130G>A (p.Val44Ile) single nucleotide variant Townes-Brocks syndrome 1 [RCV000416591]|not provided [RCV001557042] Chr16:51142092 [GRCh38]
Chr16:51176003 [GRCh37]
Chr16:16q12.1
likely benign|uncertain significance
NM_002968.3(SALL1):c.3326C>T (p.Pro1109Leu) single nucleotide variant not provided [RCV000480807] Chr16:51138896 [GRCh38]
Chr16:51172807 [GRCh37]
Chr16:16q12.1
likely pathogenic
NM_002968.3(SALL1):c.1380_1381del (p.Ser460fs) deletion not provided [RCV000479335] Chr16:51140841..51140842 [GRCh38]
Chr16:51174752..51174753 [GRCh37]
Chr16:16q12.1
pathogenic
NM_002968.3(SALL1):c.3414_3415del (p.Cys1139fs) deletion Townes syndrome [RCV000526857]|Townes-Brocks syndrome 1 [RCV000007863]|not provided [RCV000486755] Chr16:51138807..51138808 [GRCh38]
Chr16:51172718..51172719 [GRCh37]
Chr16:16q12.1
pathogenic
GRCh37/hg19 16p11.2-q21(chr16:34197492-64509054)x3 copy number gain See cases [RCV000511791] Chr16:34197492..64509054 [GRCh37]
Chr16:16p11.2-q21
pathogenic
GRCh37/hg19 16p13.2-q24.3(chr16:9273328-89548493)x3 copy number gain See cases [RCV000511622] Chr16:9273328..89548493 [GRCh37]
Chr16:16p13.2-q24.3
uncertain significance
GRCh37/hg19 16q11.2-12.1(chr16:46737110-51838691)x1 copy number loss See cases [RCV000511950] Chr16:46737110..51838691 [GRCh37]
Chr16:16q11.2-12.1
pathogenic
GRCh37/hg19 16q11.2-24.3(chr16:46497599-90354753)x1 copy number loss Poly (ADP-Ribose) polymerase inhibitor response [RCV000626429] Chr16:46497599..90354753 [GRCh37]
Chr16:16q11.2-24.3
drug response
NM_002968.3(SALL1):c.264C>T (p.Ser88=) single nucleotide variant Townes syndrome [RCV000634157]|Townes-Brocks syndrome 1 [RCV002507068]|not provided [RCV001672902] Chr16:51141958 [GRCh38]
Chr16:51175869 [GRCh37]
Chr16:16q12.1
benign|likely benign
NC_000016.10:g.(?_51137092)_(51151261_?)del deletion Townes syndrome [RCV000634158] Chr16:51137092..51151261 [GRCh38]
Chr16:51171003..51185172 [GRCh37]
Chr16:16q12.1
pathogenic
NM_002968.3(SALL1):c.477_478insAGCAGCGGC (p.Ser159_Gly160insSerSerGly) insertion Townes-Brocks syndrome 1 [RCV000626257]|not provided [RCV002285382] Chr16:51141744..51141745 [GRCh38]
Chr16:51175655..51175656 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.572T>C (p.Ile191Thr) single nucleotide variant not provided [RCV000585096] Chr16:51141650 [GRCh38]
Chr16:51175561 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.387C>T (p.Ala129=) single nucleotide variant Townes syndrome [RCV002064380]|Townes-Brocks syndrome 1 [RCV002491295]|not specified [RCV000609960] Chr16:51141835 [GRCh38]
Chr16:51175746 [GRCh37]
Chr16:16q12.1
likely benign
GRCh37/hg19 16p13.3-q24.3(chr16:85881-90155062) copy number gain See cases [RCV000511296] Chr16:85881..90155062 [GRCh37]
Chr16:16p13.3-q24.3
pathogenic
NM_002968.3(SALL1):c.2278C>T (p.Pro760Ser) single nucleotide variant Townes-Brocks syndrome 1 [RCV002282256]|not provided [RCV000594770] Chr16:51139944 [GRCh38]
Chr16:51173855 [GRCh37]
Chr16:16q12.1
uncertain significance
GRCh37/hg19 16q11.2-24.3(chr16:46455960-90354753)x1 copy number loss Poly (ADP-Ribose) polymerase inhibitor response [RCV000626435] Chr16:46455960..90354753 [GRCh37]
Chr16:16q11.2-24.3
drug response
NM_002968.3(SALL1):c.866T>A (p.Leu289Ter) single nucleotide variant Townes syndrome [RCV000634150] Chr16:51141356 [GRCh38]
Chr16:51175267 [GRCh37]
Chr16:16q12.1
pathogenic
NM_002968.3(SALL1):c.958C>T (p.Gln320Ter) single nucleotide variant Townes syndrome [RCV000634151] Chr16:51141264 [GRCh38]
Chr16:51175175 [GRCh37]
Chr16:16q12.1
pathogenic
NM_002968.3(SALL1):c.2356del (p.Arg786fs) deletion Townes syndrome [RCV000634153] Chr16:51139866 [GRCh38]
Chr16:51173777 [GRCh37]
Chr16:16q12.1
pathogenic
NM_002968.3(SALL1):c.1014T>G (p.Ser338=) single nucleotide variant Townes syndrome [RCV000634156] Chr16:51141208 [GRCh38]
Chr16:51175119 [GRCh37]
Chr16:16q12.1
likely benign
GRCh37/hg19 16p13.3-q24.3(chr16:85881-90155062)x3 copy number gain See cases [RCV000512138] Chr16:85881..90155062 [GRCh37]
Chr16:16p13.3-q24.3
pathogenic
NM_002968.3(SALL1):c.712C>T (p.Gln238Ter) single nucleotide variant Townes syndrome [RCV001386803]|not provided [RCV000681840] Chr16:51141510 [GRCh38]
Chr16:51175421 [GRCh37]
Chr16:16q12.1
pathogenic|likely pathogenic
NM_002968.3(SALL1):c.3584G>A (p.Arg1195Gln) single nucleotide variant Inborn genetic diseases [RCV003163206]|Townes syndrome [RCV000696783] Chr16:51137503 [GRCh38]
Chr16:51171414 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.3322G>A (p.Val1108Ile) single nucleotide variant Townes-Brocks syndrome 1 [RCV002478943]|not specified [RCV001002753] Chr16:51138900 [GRCh38]
Chr16:51172811 [GRCh37]
Chr16:16q12.1
likely benign
GRCh37/hg19 16p13.3-q24.3(chr16:88165-90163275)x3 copy number gain not provided [RCV000738917] Chr16:88165..90163275 [GRCh37]
Chr16:16p13.3-q24.3
pathogenic
Single allele duplication not provided [RCV001542388] Chr16:46385317..61223349 [GRCh38]
Chr16:16q11.2-21
pathogenic
GRCh37/hg19 16p13.3-q24.3(chr16:88165-90274695)x3 copy number gain not provided [RCV000738918] Chr16:88165..90274695 [GRCh37]
Chr16:16p13.3-q24.3
pathogenic
GRCh37/hg19 16p13.3-q24.3(chr16:61451-90294632)x3 copy number gain not provided [RCV000738915] Chr16:61451..90294632 [GRCh37]
Chr16:16p13.3-q24.3
pathogenic
NM_002968.3(SALL1):c.424G>C (p.Gly142Arg) single nucleotide variant Townes-Brocks syndrome 1 [RCV001542321] Chr16:51141798 [GRCh38]
Chr16:51175709 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.39A>G (p.Gln13=) single nucleotide variant Townes syndrome [RCV002072990]|not provided [RCV001646074] Chr16:51151203 [GRCh38]
Chr16:51185114 [GRCh37]
Chr16:16q12.1
benign
NM_002968.3(SALL1):c.592G>A (p.Glu198Lys) single nucleotide variant not provided [RCV001583060] Chr16:51141630 [GRCh38]
Chr16:51175541 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.1022T>C (p.Met341Thr) single nucleotide variant not provided [RCV000904128] Chr16:51141200 [GRCh38]
Chr16:51175111 [GRCh37]
Chr16:16q12.1
likely benign
NM_002968.3(SALL1):c.703G>A (p.Ala235Thr) single nucleotide variant Congenital anomaly of kidney and urinary tract [RCV001849463]|Townes-Brocks syndrome 1 [RCV001254690]|not provided [RCV000951173] Chr16:51141519 [GRCh38]
Chr16:51175430 [GRCh37]
Chr16:16q12.1
likely pathogenic|likely benign|uncertain significance
NM_002968.3(SALL1):c.1485C>T (p.His495=) single nucleotide variant not provided [RCV000905621] Chr16:51140737 [GRCh38]
Chr16:51174648 [GRCh37]
Chr16:16q12.1
likely benign
NM_002968.3(SALL1):c.3957G>A (p.Lys1319=) single nucleotide variant Townes syndrome [RCV002065492] Chr16:51137130 [GRCh38]
Chr16:51171041 [GRCh37]
Chr16:16q12.1
likely benign
NM_002968.3(SALL1):c.1200G>A (p.Ser400=) single nucleotide variant Townes syndrome [RCV002546005] Chr16:51141022 [GRCh38]
Chr16:51174933 [GRCh37]
Chr16:16q12.1
benign
NM_002968.3(SALL1):c.3964G>A (p.Val1322Ile) single nucleotide variant Inborn genetic diseases [RCV002549932]|Townes syndrome [RCV002067616]|not provided [RCV000996269] Chr16:51137123 [GRCh38]
Chr16:51171034 [GRCh37]
Chr16:16q12.1
likely benign|uncertain significance
NM_002968.3(SALL1):c.2686_2689dup (p.Val897fs) duplication Townes-Brocks syndrome 1 [RCV000995629] Chr16:51139532..51139533 [GRCh38]
Chr16:51173443..51173444 [GRCh37]
Chr16:16q12.1
pathogenic
NM_002968.3(SALL1):c.3759C>T (p.Ser1253=) single nucleotide variant Townes syndrome [RCV000874421]|not provided [RCV001546381] Chr16:51137328 [GRCh38]
Chr16:51171239 [GRCh37]
Chr16:16q12.1
likely benign
NM_002968.3(SALL1):c.3084A>G (p.Pro1028=) single nucleotide variant Townes-Brocks syndrome 1 [RCV002507517]|not provided [RCV000871943] Chr16:51139138 [GRCh38]
Chr16:51173049 [GRCh37]
Chr16:16q12.1
likely benign
NM_002968.3(SALL1):c.3836C>T (p.Thr1279Met) single nucleotide variant Inborn genetic diseases [RCV002552026]|Townes syndrome [RCV002552027]|Townes-Brocks syndrome 1 [RCV001029863]|not provided [RCV001566703] Chr16:51137251 [GRCh38]
Chr16:51171162 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.2050C>T (p.Gln684Ter) single nucleotide variant Townes-Brocks syndrome 1 [RCV001029950] Chr16:51140172 [GRCh38]
Chr16:51174083 [GRCh37]
Chr16:16q12.1
likely pathogenic|uncertain significance
NM_002968.3(SALL1):c.3005_3008del (p.Ala1002fs) deletion Townes syndrome [RCV000821059] Chr16:51139214..51139217 [GRCh38]
Chr16:51173125..51173128 [GRCh37]
Chr16:16q12.1
pathogenic
NM_002968.3(SALL1):c.448AGC[13] (p.Ser157_Ser159dup) microsatellite Townes syndrome [RCV000871313]|Townes-Brocks syndrome 1 [RCV002478980]|not provided [RCV001573512]|not specified [RCV001529319] Chr16:51141744..51141745 [GRCh38]
Chr16:51175655..51175656 [GRCh37]
Chr16:16q12.1
benign|likely benign
NM_002968.3(SALL1):c.2287dup (p.Arg763fs) duplication Townes-Brocks syndrome 1 [RCV001029980] Chr16:51139934..51139935 [GRCh38]
Chr16:51173845..51173846 [GRCh37]
Chr16:16q12.1
likely pathogenic
NM_002968.3(SALL1):c.3535-207G>A single nucleotide variant not provided [RCV000826350] Chr16:51137759 [GRCh38]
Chr16:51171670 [GRCh37]
Chr16:16q12.1
benign
NM_002968.3(SALL1):c.1324del (p.Ser442fs) deletion Townes syndrome [RCV000803639] Chr16:51140898 [GRCh38]
Chr16:51174809 [GRCh37]
Chr16:16q12.1
pathogenic
NM_002968.3(SALL1):c.1738A>G (p.Ile580Val) single nucleotide variant Townes syndrome [RCV002535705]|not provided [RCV000782252]|not specified [RCV002249483] Chr16:51140484 [GRCh38]
Chr16:51174395 [GRCh37]
Chr16:16q12.1
benign|likely benign|uncertain significance
NM_002968.3(SALL1):c.602A>G (p.Gln201Arg) single nucleotide variant Townes-Brocks syndrome 1 [RCV002501022]|VACTERL with hydrocephalus [RCV001007926]|not provided [RCV000782264] Chr16:51141620 [GRCh38]
Chr16:51175531 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.548C>A (p.Thr183Lys) single nucleotide variant Townes syndrome [RCV000810771]|Townes-Brocks syndrome 1 [RCV002487762] Chr16:51141674 [GRCh38]
Chr16:51175585 [GRCh37]
Chr16:16q12.1
likely benign|uncertain significance
NM_002968.3(SALL1):c.2409dup (p.Glu804Ter) duplication not provided [RCV001008730] Chr16:51139812..51139813 [GRCh38]
Chr16:51173723..51173724 [GRCh37]
Chr16:16q12.1
likely pathogenic
NM_002968.3(SALL1):c.1873G>T (p.Glu625Ter) single nucleotide variant Townes-Brocks syndrome 1 [RCV001249670] Chr16:51140349 [GRCh38]
Chr16:51174260 [GRCh37]
Chr16:16q12.1
pathogenic
NM_002968.3(SALL1):c.3787A>G (p.Ile1263Val) single nucleotide variant Townes-Brocks syndrome 1 [RCV001199084] Chr16:51137300 [GRCh38]
Chr16:51171211 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.3847G>A (p.Glu1283Lys) single nucleotide variant Townes-Brocks syndrome 1 [RCV001250545] Chr16:51137240 [GRCh38]
Chr16:51171151 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.2069A>G (p.Lys690Arg) single nucleotide variant not provided [RCV001576885] Chr16:51140153 [GRCh38]
Chr16:51174064 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.1326C>T (p.Ser442=) single nucleotide variant not provided [RCV001566978] Chr16:51140896 [GRCh38]
Chr16:51174807 [GRCh37]
Chr16:16q12.1
likely benign
NM_002968.3(SALL1):c.565_566dup (p.Val190fs) microsatellite not provided [RCV001570574] Chr16:51141655..51141656 [GRCh38]
Chr16:51175566..51175567 [GRCh37]
Chr16:16q12.1
pathogenic
NM_002968.3(SALL1):c.1113ATC[1] (p.Ser375del) microsatellite Townes syndrome [RCV002573203]|not provided [RCV001567690] Chr16:51141104..51141106 [GRCh38]
Chr16:51175015..51175017 [GRCh37]
Chr16:16q12.1
likely benign|uncertain significance
NM_002968.3(SALL1):c.1759C>A (p.Pro587Thr) single nucleotide variant Townes-Brocks syndrome 1 [RCV001533179] Chr16:51140463 [GRCh38]
Chr16:51174374 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.3963C>G (p.Ile1321Met) single nucleotide variant not provided [RCV001695461] Chr16:51137124 [GRCh38]
Chr16:51171035 [GRCh37]
Chr16:16q12.1
benign
NM_002968.3(SALL1):c.77-91A>G single nucleotide variant not provided [RCV001597995] Chr16:51142236 [GRCh38]
Chr16:51176147 [GRCh37]
Chr16:16q12.1
benign
NM_002968.3(SALL1):c.*83GCCCC[3] microsatellite not provided [RCV001656748] Chr16:51137019..51137020 [GRCh38]
Chr16:51170930..51170931 [GRCh37]
Chr16:16q12.1
benign
NM_002968.3(SALL1):c.1514A>G (p.His505Arg) single nucleotide variant Townes-Brocks syndrome 1 [RCV000855402] Chr16:51140708 [GRCh38]
Chr16:51174619 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.2752G>A (p.Ala918Thr) single nucleotide variant Inborn genetic diseases [RCV002550579]|Townes syndrome [RCV001423298]|not provided [RCV000983808] Chr16:51139470 [GRCh38]
Chr16:51173381 [GRCh37]
Chr16:16q12.1
benign|likely benign|uncertain significance
NM_002968.3(SALL1):c.2798_2803dup (p.Asn933_Ser934dup) duplication Townes syndrome [RCV002540155] Chr16:51139418..51139419 [GRCh38]
Chr16:51173329..51173330 [GRCh37]
Chr16:16q12.1
likely benign
NM_002968.3(SALL1):c.420del (p.Ser141fs) deletion Townes syndrome [RCV001203386] Chr16:51141802 [GRCh38]
Chr16:51175713 [GRCh37]
Chr16:16q12.1
pathogenic
NM_002968.3(SALL1):c.475_476insAGC (p.Ser159delinsLysArg) insertion not provided [RCV001656612] Chr16:51141746..51141747 [GRCh38]
Chr16:51175657..51175658 [GRCh37]
Chr16:16q12.1
benign
NM_002968.3(SALL1):c.3330T>C (p.Ser1110=) single nucleotide variant Townes-Brocks syndrome 1 [RCV002501899]|not provided [RCV001557100] Chr16:51138892 [GRCh38]
Chr16:51172803 [GRCh37]
Chr16:16q12.1
likely benign
NM_002968.3(SALL1):c.939G>T (p.Val313=) single nucleotide variant not provided [RCV001559038] Chr16:51141283 [GRCh38]
Chr16:51175194 [GRCh37]
Chr16:16q12.1
likely benign
NM_002968.3(SALL1):c.1872C>T (p.Ser624=) single nucleotide variant not provided [RCV001561295] Chr16:51140350 [GRCh38]
Chr16:51174261 [GRCh37]
Chr16:16q12.1
likely benign
NM_002968.3(SALL1):c.1732A>G (p.Ile578Val) single nucleotide variant not provided [RCV002467266] Chr16:51140490 [GRCh38]
Chr16:51174401 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.2712_2715del (p.Gly906fs) deletion not provided [RCV001008523] Chr16:51139507..51139510 [GRCh38]
Chr16:51173418..51173421 [GRCh37]
Chr16:16q12.1
likely pathogenic
NM_002968.3(SALL1):c.2801del (p.Ser934fs) deletion Townes-Brocks syndrome 1 [RCV001029827] Chr16:51139421 [GRCh38]
Chr16:51173332 [GRCh37]
Chr16:16q12.1
likely pathogenic
NM_002968.3(SALL1):c.104G>A (p.Arg35His) single nucleotide variant not provided [RCV001537357] Chr16:51142118 [GRCh38]
Chr16:51176029 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.3534+40C>G single nucleotide variant not provided [RCV001608247] Chr16:51138648 [GRCh38]
Chr16:51172559 [GRCh37]
Chr16:16q12.1
benign
NM_002968.3(SALL1):c.2331C>T (p.Asn777=) single nucleotide variant Townes syndrome [RCV002073181]|Townes-Brocks syndrome 1 [RCV002496001]|not provided [RCV001676474] Chr16:51139891 [GRCh38]
Chr16:51173802 [GRCh37]
Chr16:16q12.1
benign|likely benign
NM_002968.3(SALL1):c.77-54G>A single nucleotide variant not provided [RCV001596180] Chr16:51142199 [GRCh38]
Chr16:51176110 [GRCh37]
Chr16:16q12.1
likely benign
NM_002968.3(SALL1):c.1565C>T (p.Thr522Met) single nucleotide variant Townes-Brocks syndrome 1 [RCV002488463]|not provided [RCV001686235] Chr16:51140657 [GRCh38]
Chr16:51174568 [GRCh37]
Chr16:16q12.1
benign|likely benign
NM_002968.3(SALL1):c.3068A>C (p.His1023Pro) single nucleotide variant not provided [RCV001586857] Chr16:51139154 [GRCh38]
Chr16:51173065 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.3534+274G>C single nucleotide variant not provided [RCV001686887] Chr16:51138414 [GRCh38]
Chr16:51172325 [GRCh37]
Chr16:16q12.1
benign
NM_002968.3(SALL1):c.3603C>T (p.Gly1201=) single nucleotide variant not provided [RCV001656076] Chr16:51137484 [GRCh38]
Chr16:51171395 [GRCh37]
Chr16:16q12.1
benign
NM_002968.3(SALL1):c.1207C>T (p.Pro403Ser) single nucleotide variant Townes-Brocks syndrome 1 [RCV002477863]|not provided [RCV001596607] Chr16:51141015 [GRCh38]
Chr16:51174926 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.3322G>C (p.Val1108Leu) single nucleotide variant Townes syndrome [RCV002570646]|not provided [RCV001541299] Chr16:51138900 [GRCh38]
Chr16:51172811 [GRCh37]
Chr16:16q12.1
benign|likely benign
NM_002968.3(SALL1):c.2315A>G (p.Gln772Arg) single nucleotide variant not provided [RCV001588648] Chr16:51139907 [GRCh38]
Chr16:51173818 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.2573_2574delinsAA (p.Leu858Gln) indel not provided [RCV001667708] Chr16:51139648..51139649 [GRCh38]
Chr16:51173559..51173560 [GRCh37]
Chr16:16q12.1
benign
NM_002968.3(SALL1):c.3729C>T (p.Asn1243=) single nucleotide variant Townes syndrome [RCV002538599]|Townes-Brocks syndrome 1 [RCV002502017]|not provided [RCV001670243] Chr16:51137358 [GRCh38]
Chr16:51171269 [GRCh37]
Chr16:16q12.1
benign|likely benign
NM_002968.3(SALL1):c.76+68_76+69del deletion not provided [RCV001714315] Chr16:51151097..51151098 [GRCh38]
Chr16:51185008..51185009 [GRCh37]
Chr16:16q12.1
benign
NM_002968.3(SALL1):c.388_391delinsTTTGCTAACAAAGCGGCAGCGGCACTT (p.Pro130fs) indel not provided [RCV001537002] Chr16:51141831..51141834 [GRCh38]
Chr16:51175742..51175745 [GRCh37]
Chr16:16q12.1
pathogenic
NM_002968.3(SALL1):c.2259C>T (p.Tyr753=) single nucleotide variant Townes-Brocks syndrome 1 [RCV002495943]|not provided [RCV001583881] Chr16:51139963 [GRCh38]
Chr16:51173874 [GRCh37]
Chr16:16q12.1
likely benign
NM_002968.3(SALL1):c.76+187C>T single nucleotide variant not provided [RCV001682412] Chr16:51150979 [GRCh38]
Chr16:51184890 [GRCh37]
Chr16:16q12.1
benign
NM_002968.3(SALL1):c.3242T>C (p.Leu1081Ser) single nucleotide variant not provided [RCV001589924] Chr16:51138980 [GRCh38]
Chr16:51172891 [GRCh37]
Chr16:16q12.1
likely benign
NM_002968.3(SALL1):c.750dup (p.Arg251fs) duplication Townes syndrome [RCV001218743] Chr16:51141471..51141472 [GRCh38]
Chr16:51175382..51175383 [GRCh37]
Chr16:16q12.1
pathogenic
NM_002968.3(SALL1):c.871C>T (p.Gln291Ter) single nucleotide variant Townes syndrome [RCV001205091] Chr16:51141351 [GRCh38]
Chr16:51175262 [GRCh37]
Chr16:16q12.1
pathogenic
NM_002968.3(SALL1):c.412G>A (p.Gly138Ser) single nucleotide variant Townes syndrome [RCV001069839]|Townes-Brocks syndrome 1 [RCV002505657]|not provided [RCV002469341] Chr16:51141810 [GRCh38]
Chr16:51175721 [GRCh37]
Chr16:16q12.1
likely benign|uncertain significance
NM_002968.3(SALL1):c.424G>A (p.Gly142Ser) single nucleotide variant Townes syndrome [RCV001059302] Chr16:51141798 [GRCh38]
Chr16:51175709 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.1762C>T (p.Pro588Ser) single nucleotide variant Inborn genetic diseases [RCV002551715]|Microcephaly [RCV001252901] Chr16:51140460 [GRCh38]
Chr16:51174371 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.3782C>T (p.Pro1261Leu) single nucleotide variant Townes-Brocks syndrome 1 [RCV001262006] Chr16:51137305 [GRCh38]
Chr16:51171216 [GRCh37]
Chr16:16q12.1
uncertain significance
GRCh37/hg19 16q12.1(chr16:51025932-51360215)x3 copy number gain not provided [RCV001259854] Chr16:51025932..51360215 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.3685G>A (p.Asp1229Asn) single nucleotide variant Inborn genetic diseases [RCV003096316]|not provided [RCV002280558] Chr16:51137402 [GRCh38]
Chr16:51171313 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.1365_1366insGCAG (p.Lys456fs) insertion Townes-Brocks syndrome 1 [RCV001290092] Chr16:51140856..51140857 [GRCh38]
Chr16:51174767..51174768 [GRCh37]
Chr16:16q12.1
pathogenic
NM_002968.3(SALL1):c.477C>A (p.Ser159Arg) single nucleotide variant Congenital anomaly of kidney and urinary tract [RCV001328262]|Townes syndrome [RCV002537723]|not provided [RCV001587310] Chr16:51141745 [GRCh38]
Chr16:51175656 [GRCh37]
Chr16:16q12.1
likely benign|uncertain significance
NM_002968.3(SALL1):c.881_893dup (p.Leu299fs) duplication Townes syndrome [RCV001382908] Chr16:51141328..51141329 [GRCh38]
Chr16:51175239..51175240 [GRCh37]
Chr16:16q12.1
pathogenic
NM_002968.3(SALL1):c.448AGC[16] (p.Ser154_Ser159dup) microsatellite not provided [RCV001354092] Chr16:51141744..51141745 [GRCh38]
Chr16:51175655..51175656 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.3088A>G (p.Ile1030Val) single nucleotide variant Townes syndrome [RCV001303592]|Townes-Brocks syndrome 1 [RCV002499565] Chr16:51139134 [GRCh38]
Chr16:51173045 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.824T>A (p.Leu275Ter) single nucleotide variant not provided [RCV001311449] Chr16:51141398 [GRCh38]
Chr16:51175309 [GRCh37]
Chr16:16q12.1
pathogenic
NM_002968.3(SALL1):c.269dup (p.Pro91fs) duplication Townes-Brocks syndrome 1 [RCV001353177] Chr16:51141952..51141953 [GRCh38]
Chr16:51175863..51175864 [GRCh37]
Chr16:16q12.1
likely pathogenic
NM_002968.3(SALL1):c.2846A>G (p.Gln949Arg) single nucleotide variant Congenital anomaly of kidney and urinary tract [RCV001328263]|Townes-Brocks syndrome 1 [RCV002471076] Chr16:51139376 [GRCh38]
Chr16:51173287 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.2181A>G (p.Thr727=) single nucleotide variant Townes syndrome [RCV001399114] Chr16:51140041 [GRCh38]
Chr16:51173952 [GRCh37]
Chr16:16q12.1
likely benign
NM_002968.3(SALL1):c.3535-152C>G single nucleotide variant not provided [RCV001540391] Chr16:51137704 [GRCh38]
Chr16:51171615 [GRCh37]
Chr16:16q12.1
likely benign
NM_002968.3(SALL1):c.870dup (p.Gln291fs) duplication Townes syndrome [RCV001389539] Chr16:51141351..51141352 [GRCh38]
Chr16:51175262..51175263 [GRCh37]
Chr16:16q12.1
pathogenic
NM_002968.3(SALL1):c.1027dup (p.Ile343fs) duplication Townes syndrome [RCV001383646] Chr16:51141194..51141195 [GRCh38]
Chr16:51175105..51175106 [GRCh37]
Chr16:16q12.1
pathogenic
NM_002968.3(SALL1):c.1028dup (p.Leu344fs) duplication Townes syndrome [RCV001381951] Chr16:51141193..51141194 [GRCh38]
Chr16:51175104..51175105 [GRCh37]
Chr16:16q12.1
pathogenic
NM_002968.3(SALL1):c.1327G>A (p.Asp443Asn) single nucleotide variant not provided [RCV001648632] Chr16:51140895 [GRCh38]
Chr16:51174806 [GRCh37]
Chr16:16q12.1
benign
NM_002968.3(SALL1):c.3310C>G (p.Pro1104Ala) single nucleotide variant Townes syndrome [RCV002073251]|Townes-Brocks syndrome 1 [RCV002496012]|not provided [RCV001691630] Chr16:51138912 [GRCh38]
Chr16:51172823 [GRCh37]
Chr16:16q12.1
benign|likely benign
NM_002968.3(SALL1):c.219C>T (p.Ile73=) single nucleotide variant Townes syndrome [RCV002539686]|Townes-Brocks syndrome 1 [RCV002503150]|not provided [RCV001696128] Chr16:51142003 [GRCh38]
Chr16:51175914 [GRCh37]
Chr16:16q12.1
benign|likely benign
NM_002968.3(SALL1):c.3380C>T (p.Pro1127Leu) single nucleotide variant not provided [RCV001611728] Chr16:51138842 [GRCh38]
Chr16:51172753 [GRCh37]
Chr16:16q12.1
benign
NM_002968.3(SALL1):c.3665C>T (p.Ala1222Val) single nucleotide variant Townes syndrome [RCV002073148]|not provided [RCV001674016] Chr16:51137422 [GRCh38]
Chr16:51171333 [GRCh37]
Chr16:16q12.1
benign|likely benign
NM_002968.3(SALL1):c.1423_1424del (p.Arg475fs) microsatellite Townes syndrome [RCV001381054] Chr16:51140798..51140799 [GRCh38]
Chr16:51174709..51174710 [GRCh37]
Chr16:16q12.1
pathogenic
NM_002968.3(SALL1):c.3720G>A (p.Ala1240=) single nucleotide variant Townes syndrome [RCV001490574] Chr16:51137367 [GRCh38]
Chr16:51171278 [GRCh37]
Chr16:16q12.1
likely benign
NM_002968.3(SALL1):c.2742T>C (p.Ala914=) single nucleotide variant Townes syndrome [RCV003106846] Chr16:51139480 [GRCh38]
Chr16:51173391 [GRCh37]
Chr16:16q12.1
likely benign
NM_002968.3(SALL1):c.1363_1369delinsTGAAACA (p.Ala455_Val457delinsTer) indel Townes-Brocks syndrome 1 [RCV002226956] Chr16:51140853..51140859 [GRCh38]
Chr16:51174764..51174770 [GRCh37]
Chr16:16q12.1
pathogenic
NM_002968.3(SALL1):c.1037C>T (p.Ala346Val) single nucleotide variant not provided [RCV001756446] Chr16:51141185 [GRCh38]
Chr16:51175096 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.1510C>A (p.Pro504Thr) single nucleotide variant not provided [RCV001756447] Chr16:51140712 [GRCh38]
Chr16:51174623 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.2767A>G (p.Thr923Ala) single nucleotide variant not provided [RCV001754891] Chr16:51139455 [GRCh38]
Chr16:51173366 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.3322G>T (p.Val1108Phe) single nucleotide variant Townes-Brocks syndrome 1 [RCV002273102] Chr16:51138900 [GRCh38]
Chr16:51172811 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.494C>T (p.Ser165Phe) single nucleotide variant Townes-Brocks syndrome 1 [RCV002244120] Chr16:51141728 [GRCh38]
Chr16:51175639 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.721A>G (p.Ile241Val) single nucleotide variant Townes-Brocks syndrome 1 [RCV002245280] Chr16:51141501 [GRCh38]
Chr16:51175412 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.1301C>T (p.Thr434Ile) single nucleotide variant not specified [RCV002248174] Chr16:51140921 [GRCh38]
Chr16:51174832 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.3173C>G (p.Ser1058Cys) single nucleotide variant not provided [RCV001767051] Chr16:51139049 [GRCh38]
Chr16:51172960 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.3808G>A (p.Gly1270Arg) single nucleotide variant not specified [RCV001732882] Chr16:51137279 [GRCh38]
Chr16:51171190 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.3623G>A (p.Gly1208Asp) single nucleotide variant not provided [RCV001772513] Chr16:51137464 [GRCh38]
Chr16:51171375 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.2518A>G (p.Thr840Ala) single nucleotide variant not provided [RCV001754059] Chr16:51139704 [GRCh38]
Chr16:51173615 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.2336T>C (p.Val779Ala) single nucleotide variant not provided [RCV001767717] Chr16:51139886 [GRCh38]
Chr16:51173797 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.3631G>T (p.Val1211Phe) single nucleotide variant Townes-Brocks syndrome 1 [RCV002488566]|not provided [RCV001765474] Chr16:51137456 [GRCh38]
Chr16:51171367 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.463_475delinsG (p.Ser155_Ser159delinsGly) indel not provided [RCV001761174] Chr16:51141747..51141759 [GRCh38]
Chr16:51175658..51175670 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.3782C>G (p.Pro1261Arg) single nucleotide variant Townes-Brocks syndrome 1 [RCV002496093]|not provided [RCV001770750] Chr16:51137305 [GRCh38]
Chr16:51171216 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.2938A>T (p.Ile980Phe) single nucleotide variant Townes-Brocks syndrome 1 [RCV002478028]|not provided [RCV001797455] Chr16:51139284 [GRCh38]
Chr16:51173195 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.2493C>G (p.Asp831Glu) single nucleotide variant not provided [RCV001797514] Chr16:51139729 [GRCh38]
Chr16:51173640 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.3381del (p.Arg1128fs) deletion Townes-Brocks syndrome 1 [RCV001808305] Chr16:51138841 [GRCh38]
Chr16:51172752 [GRCh37]
Chr16:16q12.1
likely pathogenic
NM_002968.3(SALL1):c.373A>G (p.Met125Val) single nucleotide variant not provided [RCV001814731] Chr16:51141849 [GRCh38]
Chr16:51175760 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.2621A>C (p.Asn874Thr) single nucleotide variant not provided [RCV001806271] Chr16:51139601 [GRCh38]
Chr16:51173512 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.1069G>A (p.Ala357Thr) single nucleotide variant not provided [RCV001806480] Chr16:51141153 [GRCh38]
Chr16:51175064 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.2461C>G (p.Leu821Val) single nucleotide variant Townes syndrome [RCV001985232] Chr16:51139761 [GRCh38]
Chr16:51173672 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.3843C>G (p.Asn1281Lys) single nucleotide variant Townes syndrome [RCV001872121] Chr16:51137244 [GRCh38]
Chr16:51171155 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.2957T>C (p.Leu986Ser) single nucleotide variant Townes syndrome [RCV001945653]|Townes-Brocks syndrome 1 [RCV002484567] Chr16:51139265 [GRCh38]
Chr16:51173176 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.1666G>A (p.Gly556Ser) single nucleotide variant Congenital anomaly of kidney and urinary tract [RCV001849618] Chr16:51140556 [GRCh38]
Chr16:51174467 [GRCh37]
Chr16:16q12.1
likely pathogenic
NM_002968.3(SALL1):c.1227C>T (p.Ile409=) single nucleotide variant Townes syndrome [RCV001985727]|Townes-Brocks syndrome 1 [RCV002479599] Chr16:51140995 [GRCh38]
Chr16:51174906 [GRCh37]
Chr16:16q12.1
likely benign
NM_002968.3(SALL1):c.2852C>T (p.Ala951Val) single nucleotide variant Townes syndrome [RCV002020772]|Townes-Brocks syndrome 1 [RCV002479792] Chr16:51139370 [GRCh38]
Chr16:51173281 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.691del (p.Glu231fs) deletion Townes syndrome [RCV001887670] Chr16:51141531 [GRCh38]
Chr16:51175442 [GRCh37]
Chr16:16q12.1
pathogenic
NM_002968.3(SALL1):c.2452T>G (p.Phe818Val) single nucleotide variant Townes syndrome [RCV001973683] Chr16:51139770 [GRCh38]
Chr16:51173681 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.2947G>C (p.Glu983Gln) single nucleotide variant Townes syndrome [RCV001921067]|Townes-Brocks syndrome 1 [RCV002484501] Chr16:51139275 [GRCh38]
Chr16:51173186 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.3327G>A (p.Pro1109=) single nucleotide variant Townes syndrome [RCV001901849] Chr16:51138895 [GRCh38]
Chr16:51172806 [GRCh37]
Chr16:16q12.1
likely benign
NM_002968.3(SALL1):c.3728A>G (p.Asn1243Ser) single nucleotide variant Townes syndrome [RCV001972074]|Townes-Brocks syndrome 1 [RCV002491983] Chr16:51137359 [GRCh38]
Chr16:51171270 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.3890T>G (p.Leu1297Arg) single nucleotide variant Inborn genetic diseases [RCV002557708]|Townes syndrome [RCV001933223] Chr16:51137197 [GRCh38]
Chr16:51171108 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.1892C>T (p.Thr631Ile) single nucleotide variant Townes syndrome [RCV002014046] Chr16:51140330 [GRCh38]
Chr16:51174241 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.268C>T (p.Pro90Ser) single nucleotide variant Townes syndrome [RCV001925167] Chr16:51141954 [GRCh38]
Chr16:51175865 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.3409A>G (p.Asn1137Asp) single nucleotide variant Townes syndrome [RCV001918658] Chr16:51138813 [GRCh38]
Chr16:51172724 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.2565T>G (p.Pro855=) single nucleotide variant Townes syndrome [RCV002091144]|Townes-Brocks syndrome 1 [RCV002498323] Chr16:51139657 [GRCh38]
Chr16:51173568 [GRCh37]
Chr16:16q12.1
likely benign
NM_002968.3(SALL1):c.471C>T (p.Ser157=) single nucleotide variant Townes syndrome [RCV002147129] Chr16:51141751 [GRCh38]
Chr16:51175662 [GRCh37]
Chr16:16q12.1
likely benign
NM_002968.3(SALL1):c.63C>T (p.Leu21=) single nucleotide variant Townes syndrome [RCV002129582] Chr16:51151179 [GRCh38]
Chr16:51185090 [GRCh37]
Chr16:16q12.1
likely benign
NM_002968.3(SALL1):c.1854A>G (p.Pro618=) single nucleotide variant Townes syndrome [RCV002175006] Chr16:51140368 [GRCh38]
Chr16:51174279 [GRCh37]
Chr16:16q12.1
likely benign
NM_002968.3(SALL1):c.1665C>T (p.Val555=) single nucleotide variant Townes syndrome [RCV003089189]|not provided [RCV002224891] Chr16:51140557 [GRCh38]
Chr16:51174468 [GRCh37]
Chr16:16q12.1
likely benign|uncertain significance
NM_002968.3(SALL1):c.3231C>T (p.Pro1077=) single nucleotide variant Townes syndrome [RCV002090379]|Townes-Brocks syndrome 1 [RCV002498112] Chr16:51138991 [GRCh38]
Chr16:51172902 [GRCh37]
Chr16:16q12.1
likely benign
NM_002968.3(SALL1):c.1953C>T (p.Pro651=) single nucleotide variant Townes syndrome [RCV002116301]|Townes-Brocks syndrome 1 [RCV002508076] Chr16:51140269 [GRCh38]
Chr16:51174180 [GRCh37]
Chr16:16q12.1
likely benign
NM_002968.3(SALL1):c.618G>A (p.Ala206=) single nucleotide variant Townes syndrome [RCV002120446]|Townes-Brocks syndrome 1 [RCV002500181] Chr16:51141604 [GRCh38]
Chr16:51175515 [GRCh37]
Chr16:16q12.1
likely benign
NM_002968.3(SALL1):c.1007G>C (p.Gly336Ala) single nucleotide variant not specified [RCV002248175] Chr16:51141215 [GRCh38]
Chr16:51175126 [GRCh37]
Chr16:16q12.1
uncertain significance
GRCh37/hg19 16q11.2-24.3(chr16:46503968-90155062)x3 copy number gain not provided [RCV002221458] Chr16:46503968..90155062 [GRCh37]
Chr16:16q11.2-24.3
pathogenic
NM_002968.3(SALL1):c.1775A>G (p.Lys592Arg) single nucleotide variant Townes-Brocks syndrome 1 [RCV002226897] Chr16:51140447 [GRCh38]
Chr16:51174358 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.1441A>G (p.Ile481Val) single nucleotide variant not provided [RCV002221856]   uncertain significance
NM_002968.3(SALL1):c.868T>C (p.Ser290Pro) single nucleotide variant Townes syndrome [RCV003110866] Chr16:51141354 [GRCh38]
Chr16:51175265 [GRCh37]
Chr16:16q12.1
uncertain significance
NC_000016.9:g.(?_51185057)_(51185152_?)del deletion Townes syndrome [RCV003113155] Chr16:51185057..51185152 [GRCh37]
Chr16:16q12.1
pathogenic
NC_000016.9:g.(?_49525186)_(51631253_?)del deletion Nephronophthisis 14 [RCV003119486] Chr16:49525186..51631253 [GRCh37]
Chr16:16q12.1
uncertain significance
NC_000016.9:g.(?_49525186)_(51631253_?)dup duplication Nephronophthisis 14 [RCV003119487] Chr16:49525186..51631253 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.652G>A (p.Gly218Arg) single nucleotide variant not provided [RCV003152214] Chr16:51141570 [GRCh38]
Chr16:51175481 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.1778G>A (p.Ser593Asn) single nucleotide variant Townes-Brocks syndrome 1 [RCV002272752] Chr16:51140444 [GRCh38]
Chr16:51174355 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.601C>T (p.Gln201Ter) single nucleotide variant Townes-Brocks syndrome 1 [RCV002226901] Chr16:51141621 [GRCh38]
Chr16:51175532 [GRCh37]
Chr16:16q12.1
pathogenic|likely pathogenic
NM_002968.3(SALL1):c.2605C>G (p.Gln869Glu) single nucleotide variant Townes-Brocks syndrome 1 [RCV003148587] Chr16:51139617 [GRCh38]
Chr16:51173528 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.709C>T (p.Gln237Ter) single nucleotide variant Townes-Brocks syndrome 1 [RCV002260954] Chr16:51141513 [GRCh38]
Chr16:51175424 [GRCh37]
Chr16:16q12.1
pathogenic
NM_002968.3(SALL1):c.469_475delinsG (p.Ser157_Ser159delinsGly) indel not provided [RCV002281358] Chr16:51141747..51141753 [GRCh38]
Chr16:51175658..51175664 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.2983C>G (p.Arg995Gly) single nucleotide variant not provided [RCV002281236] Chr16:51139239 [GRCh38]
Chr16:51173150 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.2129del (p.Ile710fs) deletion Townes-Brocks syndrome 1 [RCV002274276] Chr16:51140093 [GRCh38]
Chr16:51174004 [GRCh37]
Chr16:16q12.1
likely pathogenic
GRCh37/hg19 16q12.1(chr16:50093691-51651454)x1 copy number loss Syndromic anorectal malformation [RCV002286604] Chr16:50093691..51651454 [GRCh37]
Chr16:16q12.1
association
NM_002968.3(SALL1):c.1405C>G (p.Arg469Gly) single nucleotide variant not provided [RCV002281347] Chr16:51140817 [GRCh38]
Chr16:51174728 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.1112C>G (p.Ser371Ter) single nucleotide variant not provided [RCV002281430] Chr16:51141110 [GRCh38]
Chr16:51175021 [GRCh37]
Chr16:16q12.1
pathogenic
NM_002968.3(SALL1):c.1230A>C (p.Gly410=) single nucleotide variant not provided [RCV003129456] Chr16:51140992 [GRCh38]
Chr16:51174903 [GRCh37]
Chr16:16q12.1
likely benign
GRCh37/hg19 16q11.2-21(chr16:46503573-62203182)x3 copy number gain not provided [RCV002472562] Chr16:46503573..62203182 [GRCh37]
Chr16:16q11.2-21
pathogenic
NM_002968.3(SALL1):c.787G>T (p.Asp263Tyr) single nucleotide variant Inborn genetic diseases [RCV002990205] Chr16:51141435 [GRCh38]
Chr16:51175346 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.974G>T (p.Ser325Ile) single nucleotide variant Inborn genetic diseases [RCV002879868] Chr16:51141248 [GRCh38]
Chr16:51175159 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.1417G>T (p.Gly473Ter) single nucleotide variant Townes syndrome [RCV002837503] Chr16:51140805 [GRCh38]
Chr16:51174716 [GRCh37]
Chr16:16q12.1
pathogenic
NM_002968.3(SALL1):c.481G>A (p.Gly161Ser) single nucleotide variant Townes syndrome [RCV002971155] Chr16:51141741 [GRCh38]
Chr16:51175652 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.1556A>G (p.Asn519Ser) single nucleotide variant Townes syndrome [RCV002971222] Chr16:51140666 [GRCh38]
Chr16:51174577 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.1583A>G (p.Tyr528Cys) single nucleotide variant Townes syndrome [RCV002730816] Chr16:51140639 [GRCh38]
Chr16:51174550 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.1566G>A (p.Thr522=) single nucleotide variant Townes syndrome [RCV002907694] Chr16:51140656 [GRCh38]
Chr16:51174567 [GRCh37]
Chr16:16q12.1
likely benign
NM_002968.3(SALL1):c.2460C>T (p.Asp820=) single nucleotide variant Townes syndrome [RCV002975487] Chr16:51139762 [GRCh38]
Chr16:51173673 [GRCh37]
Chr16:16q12.1
likely benign
NM_002968.3(SALL1):c.2186C>A (p.Thr729Asn) single nucleotide variant Inborn genetic diseases [RCV002778135] Chr16:51140036 [GRCh38]
Chr16:51173947 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.109A>T (p.Thr37Ser) single nucleotide variant Townes syndrome [RCV002903366] Chr16:51142113 [GRCh38]
Chr16:51176024 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.499A>G (p.Thr167Ala) single nucleotide variant Inborn genetic diseases [RCV002700474]|Townes syndrome [RCV002681898] Chr16:51141723 [GRCh38]
Chr16:51175634 [GRCh37]
Chr16:16q12.1
benign|uncertain significance
NM_002968.3(SALL1):c.833C>T (p.Ser278Phe) single nucleotide variant Townes-Brocks syndrome 1 [RCV002510629] Chr16:51141389 [GRCh38]
Chr16:51175300 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.2130C>G (p.Ile710Met) single nucleotide variant Townes syndrome [RCV002617319] Chr16:51140092 [GRCh38]
Chr16:51174003 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.560A>C (p.Asn187Thr) single nucleotide variant Inborn genetic diseases [RCV002946565] Chr16:51141662 [GRCh38]
Chr16:51175573 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.3781C>T (p.Pro1261Ser) single nucleotide variant Inborn genetic diseases [RCV002688385] Chr16:51137306 [GRCh38]
Chr16:51171217 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.1784C>T (p.Ser595Phe) single nucleotide variant not provided [RCV002462503] Chr16:51140438 [GRCh38]
Chr16:51174349 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.827G>C (p.Arg276Pro) single nucleotide variant Townes syndrome [RCV003097603] Chr16:51141395 [GRCh38]
Chr16:51175306 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.246C>T (p.Pro82=) single nucleotide variant Townes syndrome [RCV002615047] Chr16:51141976 [GRCh38]
Chr16:51175887 [GRCh37]
Chr16:16q12.1
likely benign
NM_002968.3(SALL1):c.448AGC[6] (p.Ser156_Ser159del) microsatellite not provided [RCV002461625] Chr16:51141745..51141756 [GRCh38]
Chr16:51175656..51175667 [GRCh37]
Chr16:16q12.1
likely benign
NM_002968.3(SALL1):c.1135G>T (p.Ala379Ser) single nucleotide variant Townes syndrome [RCV002755212] Chr16:51141087 [GRCh38]
Chr16:51174998 [GRCh37]
Chr16:16q12.1
likely benign
NM_002968.3(SALL1):c.9G>A (p.Arg3=) single nucleotide variant Townes syndrome [RCV002975262] Chr16:51151233 [GRCh38]
Chr16:51185144 [GRCh37]
Chr16:16q12.1
likely benign
NM_002968.3(SALL1):c.460_480del (p.Ser154_Gly160del) deletion Townes syndrome [RCV002885661] Chr16:51141742..51141762 [GRCh38]
Chr16:51175653..51175673 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.368A>G (p.Glu123Gly) single nucleotide variant Inborn genetic diseases [RCV002869289] Chr16:51141854 [GRCh38]
Chr16:51175765 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.2589C>T (p.Ile863=) single nucleotide variant Townes syndrome [RCV002953731] Chr16:51139633 [GRCh38]
Chr16:51173544 [GRCh37]
Chr16:16q12.1
likely benign
NM_002968.3(SALL1):c.1948G>A (p.Gly650Ser) single nucleotide variant Inborn genetic diseases [RCV003022002]|Townes syndrome [RCV003022003] Chr16:51140274 [GRCh38]
Chr16:51174185 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.2793G>A (p.Pro931=) single nucleotide variant Townes syndrome [RCV002871205] Chr16:51139429 [GRCh38]
Chr16:51173340 [GRCh37]
Chr16:16q12.1
likely benign
NM_002968.3(SALL1):c.1807A>G (p.Arg603Gly) single nucleotide variant Inborn genetic diseases [RCV002659749] Chr16:51140415 [GRCh38]
Chr16:51174326 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.2018A>G (p.Lys673Arg) single nucleotide variant Townes syndrome [RCV002909393] Chr16:51140204 [GRCh38]
Chr16:51174115 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.1589T>G (p.Met530Arg) single nucleotide variant Townes syndrome [RCV002976444] Chr16:51140633 [GRCh38]
Chr16:51174544 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.3095C>T (p.Thr1032Ile) single nucleotide variant Townes syndrome [RCV002923769] Chr16:51139127 [GRCh38]
Chr16:51173038 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.3537A>G (p.Val1179=) single nucleotide variant Townes syndrome [RCV002885714] Chr16:51137550 [GRCh38]
Chr16:51171461 [GRCh37]
Chr16:16q12.1
likely benign
NM_002968.3(SALL1):c.448AGC[8] (p.Ser158_Ser159del) microsatellite Townes syndrome [RCV002926682] Chr16:51141745..51141750 [GRCh38]
Chr16:51175656..51175661 [GRCh37]
Chr16:16q12.1
likely benign
NM_002968.3(SALL1):c.3737C>T (p.Ala1246Val) single nucleotide variant Inborn genetic diseases [RCV002980648] Chr16:51137350 [GRCh38]
Chr16:51171261 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.1636C>G (p.Pro546Ala) single nucleotide variant Townes syndrome [RCV002781163] Chr16:51140586 [GRCh38]
Chr16:51174497 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.567C>G (p.Ser189=) single nucleotide variant Townes syndrome [RCV002636749] Chr16:51141655 [GRCh38]
Chr16:51175566 [GRCh37]
Chr16:16q12.1
likely benign
NM_002968.3(SALL1):c.3347C>T (p.Ser1116Phe) single nucleotide variant Townes syndrome [RCV002927600] Chr16:51138875 [GRCh38]
Chr16:51172786 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.663G>C (p.Gly221=) single nucleotide variant Townes syndrome [RCV002893952] Chr16:51141559 [GRCh38]
Chr16:51175470 [GRCh37]
Chr16:16q12.1
likely benign
NM_002968.3(SALL1):c.1225A>G (p.Ile409Val) single nucleotide variant Townes syndrome [RCV003085868] Chr16:51140997 [GRCh38]
Chr16:51174908 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.2046A>G (p.Ser682=) single nucleotide variant Townes syndrome [RCV003023536] Chr16:51140176 [GRCh38]
Chr16:51174087 [GRCh37]
Chr16:16q12.1
likely benign
NM_002968.3(SALL1):c.2070G>A (p.Lys690=) single nucleotide variant Townes syndrome [RCV003084035] Chr16:51140152 [GRCh38]
Chr16:51174063 [GRCh37]
Chr16:16q12.1
likely benign
NM_002968.3(SALL1):c.469_512dup (p.Ile172fs) duplication Townes syndrome [RCV003022290] Chr16:51141709..51141710 [GRCh38]
Chr16:51175620..51175621 [GRCh37]
Chr16:16q12.1
pathogenic
NM_002968.3(SALL1):c.1921G>A (p.Val641Ile) single nucleotide variant Townes syndrome [RCV002982414] Chr16:51140301 [GRCh38]
Chr16:51174212 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.77-5T>A single nucleotide variant Townes syndrome [RCV003059598] Chr16:51142150 [GRCh38]
Chr16:51176061 [GRCh37]
Chr16:16q12.1
likely benign
NM_002968.3(SALL1):c.1350G>A (p.Lys450=) single nucleotide variant Townes syndrome [RCV002711051] Chr16:51140872 [GRCh38]
Chr16:51174783 [GRCh37]
Chr16:16q12.1
likely benign
NM_002968.3(SALL1):c.2643A>G (p.Leu881=) single nucleotide variant Townes syndrome [RCV002919118] Chr16:51139579 [GRCh38]
Chr16:51173490 [GRCh37]
Chr16:16q12.1
likely benign
NM_002968.3(SALL1):c.2873A>G (p.Asn958Ser) single nucleotide variant Inborn genetic diseases [RCV003006696] Chr16:51139349 [GRCh38]
Chr16:51173260 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.1217T>C (p.Leu406Ser) single nucleotide variant Inborn genetic diseases [RCV002742879] Chr16:51141005 [GRCh38]
Chr16:51174916 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.2273C>A (p.Ala758Asp) single nucleotide variant Inborn genetic diseases [RCV002893454] Chr16:51139949 [GRCh38]
Chr16:51173860 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.874C>T (p.Gln292Ter) single nucleotide variant Townes syndrome [RCV003058499] Chr16:51141348 [GRCh38]
Chr16:51175259 [GRCh37]
Chr16:16q12.1
pathogenic
NM_002968.3(SALL1):c.406G>A (p.Gly136Ser) single nucleotide variant Inborn genetic diseases [RCV002644762] Chr16:51141816 [GRCh38]
Chr16:51175727 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.2436C>A (p.Ser812=) single nucleotide variant Townes syndrome [RCV002982163] Chr16:51139786 [GRCh38]
Chr16:51173697 [GRCh37]
Chr16:16q12.1
likely benign
NM_002968.3(SALL1):c.1955C>T (p.Ala652Val) single nucleotide variant Townes syndrome [RCV002918501] Chr16:51140267 [GRCh38]
Chr16:51174178 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.3696C>G (p.Ser1232Arg) single nucleotide variant Inborn genetic diseases [RCV002744674] Chr16:51137391 [GRCh38]
Chr16:51171302 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.2504G>A (p.Gly835Asp) single nucleotide variant Inborn genetic diseases [RCV002955176] Chr16:51139718 [GRCh38]
Chr16:51173629 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.2393T>G (p.Val798Gly) single nucleotide variant Townes syndrome [RCV002594461] Chr16:51139829 [GRCh38]
Chr16:51173740 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.2204A>G (p.Lys735Arg) single nucleotide variant Townes syndrome [RCV002649835] Chr16:51140018 [GRCh38]
Chr16:51173929 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.76+15C>A single nucleotide variant Townes syndrome [RCV002966740] Chr16:51151151 [GRCh38]
Chr16:51185062 [GRCh37]
Chr16:16q12.1
likely benign
NM_002968.3(SALL1):c.3180C>T (p.Leu1060=) single nucleotide variant Townes syndrome [RCV003090922] Chr16:51139042 [GRCh38]
Chr16:51172953 [GRCh37]
Chr16:16q12.1
likely benign
NM_002968.3(SALL1):c.2030G>C (p.Gly677Ala) single nucleotide variant Townes syndrome [RCV002633141] Chr16:51140192 [GRCh38]
Chr16:51174103 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.3801C>T (p.Leu1267=) single nucleotide variant Townes syndrome [RCV002630512] Chr16:51137286 [GRCh38]
Chr16:51171197 [GRCh37]
Chr16:16q12.1
likely benign
NM_002968.3(SALL1):c.61C>A (p.Leu21Ile) single nucleotide variant Townes syndrome [RCV002601470] Chr16:51151181 [GRCh38]
Chr16:51185092 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.801T>C (p.Ser267=) single nucleotide variant Townes syndrome [RCV003044802] Chr16:51141421 [GRCh38]
Chr16:51175332 [GRCh37]
Chr16:16q12.1
likely benign
NM_002968.3(SALL1):c.878_887del (p.Leu293fs) deletion Townes syndrome [RCV002898877] Chr16:51141335..51141344 [GRCh38]
Chr16:51175246..51175255 [GRCh37]
Chr16:16q12.1
pathogenic
NM_002968.3(SALL1):c.3937C>T (p.Arg1313Cys) single nucleotide variant Townes syndrome [RCV002933853] Chr16:51137150 [GRCh38]
Chr16:51171061 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.2343G>A (p.Leu781=) single nucleotide variant Townes syndrome [RCV003008978] Chr16:51139879 [GRCh38]
Chr16:51173790 [GRCh37]
Chr16:16q12.1
benign
NM_002968.3(SALL1):c.662G>A (p.Gly221Glu) single nucleotide variant Townes syndrome [RCV002933523] Chr16:51141560 [GRCh38]
Chr16:51175471 [GRCh37]
Chr16:16q12.1
likely benign
NM_002968.3(SALL1):c.1030T>C (p.Leu344=) single nucleotide variant Townes syndrome [RCV003086321] Chr16:51141192 [GRCh38]
Chr16:51175103 [GRCh37]
Chr16:16q12.1
likely benign
NM_002968.3(SALL1):c.3630C>T (p.Pro1210=) single nucleotide variant Townes syndrome [RCV002715292] Chr16:51137457 [GRCh38]
Chr16:51171368 [GRCh37]
Chr16:16q12.1
likely benign
NM_002968.3(SALL1):c.2968T>C (p.Phe990Leu) single nucleotide variant Inborn genetic diseases [RCV002960053] Chr16:51139254 [GRCh38]
Chr16:51173165 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.1257G>T (p.Leu419Phe) single nucleotide variant Inborn genetic diseases [RCV002988254] Chr16:51140965 [GRCh38]
Chr16:51174876 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.2105C>T (p.Ala702Val) single nucleotide variant Townes syndrome [RCV002959184] Chr16:51140117 [GRCh38]
Chr16:51174028 [GRCh37]
Chr16:16q12.1
likely benign
NM_002968.3(SALL1):c.2563C>T (p.Pro855Ser) single nucleotide variant Townes syndrome [RCV003087375] Chr16:51139659 [GRCh38]
Chr16:51173570 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.2269C>T (p.Arg757Cys) single nucleotide variant Townes syndrome [RCV002967193]|Townes-Brocks syndrome 1 [RCV003138418] Chr16:51139953 [GRCh38]
Chr16:51173864 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.2923A>G (p.Ser975Gly) single nucleotide variant Inborn genetic diseases [RCV002747777] Chr16:51139299 [GRCh38]
Chr16:51173210 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.1210A>C (p.Ser404Arg) single nucleotide variant Townes syndrome [RCV002959144]|not provided [RCV003128957] Chr16:51141012 [GRCh38]
Chr16:51174923 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.3437C>T (p.Ser1146Leu) single nucleotide variant Townes syndrome [RCV002922925] Chr16:51138785 [GRCh38]
Chr16:51172696 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.2863G>A (p.Glu955Lys) single nucleotide variant Townes syndrome [RCV003068108] Chr16:51139359 [GRCh38]
Chr16:51173270 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.983A>G (p.Asn328Ser) single nucleotide variant Townes syndrome [RCV002658323] Chr16:51141239 [GRCh38]
Chr16:51175150 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.839A>G (p.Asn280Ser) single nucleotide variant Inborn genetic diseases [RCV002679822] Chr16:51141383 [GRCh38]
Chr16:51175294 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.1954G>A (p.Ala652Thr) single nucleotide variant Townes syndrome [RCV003070678] Chr16:51140268 [GRCh38]
Chr16:51174179 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.2117A>G (p.Asn706Ser) single nucleotide variant Townes syndrome [RCV002653722] Chr16:51140105 [GRCh38]
Chr16:51174016 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.3666G>A (p.Ala1222=) single nucleotide variant Townes syndrome [RCV002942677] Chr16:51137421 [GRCh38]
Chr16:51171332 [GRCh37]
Chr16:16q12.1
likely benign
NM_002968.3(SALL1):c.2870C>G (p.Ala957Gly) single nucleotide variant Townes syndrome [RCV003092410] Chr16:51139352 [GRCh38]
Chr16:51173263 [GRCh37]
Chr16:16q12.1
likely benign
NM_002968.3(SALL1):c.1199C>T (p.Ser400Leu) single nucleotide variant Townes syndrome [RCV002721986] Chr16:51141023 [GRCh38]
Chr16:51174934 [GRCh37]
Chr16:16q12.1
likely benign
NM_002968.3(SALL1):c.1754C>T (p.Thr585Ile) single nucleotide variant Townes syndrome [RCV003093111] Chr16:51140468 [GRCh38]
Chr16:51174379 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.1027A>G (p.Ile343Val) single nucleotide variant Inborn genetic diseases [RCV003195509] Chr16:51141195 [GRCh38]
Chr16:51175106 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.2986G>A (p.Gly996Ser) single nucleotide variant not provided [RCV003222872] Chr16:51139236 [GRCh38]
Chr16:51173147 [GRCh37]
Chr16:16q12.1
likely benign
NM_002968.3(SALL1):c.26C>G (p.Pro9Arg) single nucleotide variant not provided [RCV003224008] Chr16:51151216 [GRCh38]
Chr16:51185127 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.3832C>G (p.Leu1278Val) single nucleotide variant Inborn genetic diseases [RCV003219399] Chr16:51137255 [GRCh38]
Chr16:51171166 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.3534+25C>T single nucleotide variant not provided [RCV003222871] Chr16:51138663 [GRCh38]
Chr16:51172574 [GRCh37]
Chr16:16q12.1
likely benign
NM_002968.3(SALL1):c.442G>A (p.Ala148Thr) single nucleotide variant Inborn genetic diseases [RCV003180179] Chr16:51141780 [GRCh38]
Chr16:51175691 [GRCh37]
Chr16:16q12.1
likely benign
NM_002968.3(SALL1):c.1771G>A (p.Val591Ile) single nucleotide variant Inborn genetic diseases [RCV003181342] Chr16:51140451 [GRCh38]
Chr16:51174362 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.718C>T (p.Gln240Ter) single nucleotide variant not provided [RCV003222873] Chr16:51141504 [GRCh38]
Chr16:51175415 [GRCh37]
Chr16:16q12.1
pathogenic
NM_002968.3(SALL1):c.104G>T (p.Arg35Leu) single nucleotide variant Townes-Brocks syndrome 1 [RCV003142733] Chr16:51142118 [GRCh38]
Chr16:51176029 [GRCh37]
Chr16:16q12.1
uncertain significance
NM_002968.3(SALL1):c.38A>C (p.Gln13Pro) single nucleotide variant not provided [RCV003221589] Chr16:51151204 [GRCh38]
Chr16:51185115 [GRCh37]
Chr16:16q12.1
uncertain significance
miRNA Target Status

Predicted Target Of
Summary Value
Count of predictions:1630
Count of miRNA genes:723
Interacting mature miRNAs:818
Transcripts:ENST00000251020, ENST00000440970, ENST00000541611, ENST00000562674, ENST00000566102, ENST00000570206
Prediction methods:Miranda, Rnahybrid, Targetscan
Result types:miRGate_prediction

The detailed report is available here: Full Report CSV TAB Printer

miRNA Target Status data imported from miRGate (http://mirgate.bioinfo.cnio.es/).
For more information about miRGate, see PMID:25858286 or access the full paper here.

Markers in Region
RH47686  
Human AssemblyChrPosition (strand)SourceJBrowse
GRCh371651,169,976 - 51,170,124UniSTSGRCh37
Build 361649,727,477 - 49,727,625RGDNCBI36
Celera1635,686,344 - 35,686,492RGD
Cytogenetic Map16q12.1UniSTS
HuRef1637,058,073 - 37,058,221UniSTS
AF021116  
Human AssemblyChrPosition (strand)SourceJBrowse
GRCh371651,175,610 - 51,175,771UniSTSGRCh37
Build 361649,733,111 - 49,733,272RGDNCBI36
Celera1635,691,981 - 35,692,142RGD
Cytogenetic Map16q12.1UniSTS
HuRef1637,063,710 - 37,063,871UniSTS
SHGC-9504  
Human AssemblyChrPosition (strand)SourceJBrowse
GRCh371651,179,561 - 51,179,682UniSTSGRCh37
Build 361649,737,062 - 49,737,183RGDNCBI36
Celera1635,695,934 - 35,696,055RGD
Cytogenetic Map16q12.1UniSTS
HuRef1637,067,666 - 37,067,787UniSTS
TNG Radiation Hybrid Map1620489.0UniSTS
SALL1__5538  
Human AssemblyChrPosition (strand)SourceJBrowse
GRCh371651,170,255 - 51,171,008UniSTSGRCh37
Build 361649,727,756 - 49,728,509RGDNCBI36
Celera1635,686,623 - 35,687,375RGD
HuRef1637,058,352 - 37,059,104UniSTS


Expression


RNA-SEQ Expression
High: > 1000 TPM value   Medium: Between 11 and 1000 TPM
Low: Between 0.5 and 10 TPM   Below Cutoff: < 0.5 TPM

alimentary part of gastrointestinal system circulatory system endocrine system exocrine system hemolymphoid system hepatobiliary system integumental system musculoskeletal system nervous system renal system reproductive system respiratory system sensory system adipose tissue appendage entire extraembryonic component
High
Medium 10 4 1213 372 7 372 224 21 951 285 352 733
Low 852 247 226 112 178 78 803 44 2518 77 891 111 37 305 487 1
Below cutoff 1221 2067 249 134 742 6 2910 1694 225 35 137 457 131 816 1929 1

Sequence

Nucleotide Sequences
RefSeq Transcripts NG_007990 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  NM_001127892 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  NM_002968 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  XM_047434442 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  XM_047434443 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  XM_047434444 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  XM_054313589 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  XM_054313590 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
GenBank Nucleotide AC009166 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  AF017654 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  AF017655 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  AF074949 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  AK295103 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  AK307835 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  BC113881 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  BC113906 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  BC131548 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  BP229682 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  CH471092 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  CP068262 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  DA318592 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  EU668343 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  KT584341 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  X98833 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  Y18264 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  Y18265 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles

Reference Sequences
RefSeq Acc Id: ENST00000251020   ⟹   ENSP00000251020
RefSeq Status:
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38.p13 Ensembl1651,135,982 - 51,151,270 (-)Ensembl
RefSeq Acc Id: ENST00000440970   ⟹   ENSP00000407914
RefSeq Status:
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38.p13 Ensembl1651,136,019 - 51,152,334 (-)Ensembl
RefSeq Acc Id: ENST00000562674
RefSeq Status:
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38.p13 Ensembl1651,143,204 - 51,151,367 (-)Ensembl
RefSeq Acc Id: ENST00000566102   ⟹   ENSP00000455582
RefSeq Status:
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38.p13 Ensembl1651,137,064 - 51,151,241 (-)Ensembl
RefSeq Acc Id: ENST00000570206   ⟹   ENSP00000456777
RefSeq Status:
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38.p13 Ensembl1651,137,112 - 51,150,597 (-)Ensembl
RefSeq Acc Id: ENST00000685868   ⟹   ENSP00000509873
RefSeq Status:
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38.p13 Ensembl1651,135,996 - 51,152,300 (-)Ensembl
RefSeq Acc Id: ENST00000690502   ⟹   ENSP00000510560
RefSeq Status:
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38.p13 Ensembl1651,138,187 - 51,151,241 (-)Ensembl
RefSeq Acc Id: NM_001127892   ⟹   NP_001121364
RefSeq Status: REVIEWED
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh381651,135,982 - 51,150,597 (-)NCBI
GRCh371651,169,886 - 51,185,183 (-)ENTREZGENE
HuRef1637,057,983 - 37,073,288 (-)ENTREZGENE
CHM1_11652,577,216 - 52,591,842 (-)NCBI
T2T-CHM13v2.01656,933,839 - 56,948,471 (-)NCBI
Sequence:
RefSeq Acc Id: NM_002968   ⟹   NP_002959
RefSeq Status: REVIEWED
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh381651,135,982 - 51,151,270 (-)NCBI
GRCh371651,169,886 - 51,185,183 (-)ENTREZGENE
Build 361649,727,387 - 49,742,684 (-)NCBI Archive
HuRef1637,057,983 - 37,073,288 (-)ENTREZGENE
CHM1_11652,577,216 - 52,592,517 (-)NCBI
T2T-CHM13v2.01656,933,839 - 56,949,144 (-)NCBI
Sequence:
RefSeq Acc Id: XM_047434442   ⟹   XP_047290398
RefSeq Status:
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh381651,135,982 - 51,152,334 (-)NCBI
RefSeq Acc Id: XM_047434443   ⟹   XP_047290399
RefSeq Status:
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh381651,135,982 - 51,152,334 (-)NCBI
RefSeq Acc Id: XM_047434444   ⟹   XP_047290400
RefSeq Status:
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh381651,135,982 - 51,152,163 (-)NCBI
RefSeq Acc Id: XM_054313589   ⟹   XP_054169564
RefSeq Status:
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
T2T-CHM13v2.01656,933,839 - 56,950,082 (-)NCBI
RefSeq Acc Id: XM_054313590   ⟹   XP_054169565
RefSeq Status:
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
T2T-CHM13v2.01656,933,839 - 56,950,190 (-)NCBI
Reference Sequences
RefSeq Acc Id: NP_002959   ⟸   NM_002968
- Peptide Label: isoform a
- UniProtKB: Q9P1R0 (UniProtKB/Swiss-Prot),   Q9NSC2 (UniProtKB/Swiss-Prot)
- Sequence:
RefSeq Acc Id: NP_001121364   ⟸   NM_001127892
- Peptide Label: isoform b
- UniProtKB: Q9NSC2 (UniProtKB/Swiss-Prot)
- Sequence:
RefSeq Acc Id: ENSP00000456777   ⟸   ENST00000570206
RefSeq Acc Id: ENSP00000407914   ⟸   ENST00000440970
RefSeq Acc Id: ENSP00000455582   ⟸   ENST00000566102
RefSeq Acc Id: ENSP00000251020   ⟸   ENST00000251020
RefSeq Acc Id: ENSP00000510560   ⟸   ENST00000690502
RefSeq Acc Id: ENSP00000509873   ⟸   ENST00000685868
RefSeq Acc Id: XP_047290399   ⟸   XM_047434443
- Peptide Label: isoform X1
- UniProtKB: Q9P1R0 (UniProtKB/Swiss-Prot)
RefSeq Acc Id: XP_047290398   ⟸   XM_047434442
- Peptide Label: isoform X1
- UniProtKB: Q9P1R0 (UniProtKB/Swiss-Prot)
RefSeq Acc Id: XP_047290400   ⟸   XM_047434444
- Peptide Label: isoform X1
- UniProtKB: Q9P1R0 (UniProtKB/Swiss-Prot)
RefSeq Acc Id: XP_054169565   ⟸   XM_054313590
- Peptide Label: isoform X1
RefSeq Acc Id: XP_054169564   ⟸   XM_054313589
- Peptide Label: isoform X1
Protein Domains
C2H2-type

Protein Structures
Name Modeler Protein Id AA Range Protein Structure
AF-Q9NSC2-F1-model_v2 AlphaFold Q9NSC2 1-1324 view protein structure

Promoters
RGD ID:7232211
Promoter ID:EPDNEW_H21847
Type:initiation region
Name:SALL1_1
Description:spalt like transcription factor 1
SO ACC ID:SO:0000170
Source:EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/)
Alternative Promoters:null; see alsoEPDNEW_H21848  EPDNEW_H21849  
Experiment Methods:Single-end sequencing.
Position:
Human AssemblyChrPosition (strand)Source
GRCh381651,151,270 - 51,151,330EPDNEW
RGD ID:7232203
Promoter ID:EPDNEW_H21848
Type:initiation region
Name:SALL1_2
Description:spalt like transcription factor 1
SO ACC ID:SO:0000170
Source:EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/)
Alternative Promoters:null; see alsoEPDNEW_H21849  EPDNEW_H21847  
Experiment Methods:Single-end sequencing.; Paired-end sequencing.
Position:
Human AssemblyChrPosition (strand)Source
GRCh381651,151,661 - 51,151,721EPDNEW
RGD ID:7232205
Promoter ID:EPDNEW_H21849
Type:initiation region
Name:SALL1_3
Description:spalt like transcription factor 1
SO ACC ID:SO:0000170
Source:EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/)
Alternative Promoters:null; see alsoEPDNEW_H21848  EPDNEW_H21847  
Experiment Methods:Single-end sequencing.; Paired-end sequencing.
Position:
Human AssemblyChrPosition (strand)Source
GRCh381651,152,334 - 51,152,394EPDNEW

Additional Information

Database Acc Id Source(s)
AGR Gene HGNC:10524 AgrOrtholog
COSMIC SALL1 COSMIC
Ensembl Genes ENSG00000103449 Ensembl, ENTREZGENE, UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
Ensembl Protein ENSP00000251020 ENTREZGENE
  ENSP00000251020.4 UniProtKB/Swiss-Prot
  ENSP00000407914 ENTREZGENE
  ENSP00000407914.2 UniProtKB/Swiss-Prot
  ENSP00000455582.1 UniProtKB/TrEMBL
  ENSP00000456777 ENTREZGENE, UniProtKB/TrEMBL
  ENSP00000456777.2 UniProtKB/Swiss-Prot
  ENSP00000509873 ENTREZGENE
  ENSP00000509873.1 UniProtKB/Swiss-Prot
  ENSP00000510560.1 UniProtKB/TrEMBL
Ensembl Transcript ENST00000251020 ENTREZGENE
  ENST00000251020.9 UniProtKB/Swiss-Prot
  ENST00000440970 ENTREZGENE
  ENST00000440970.6 UniProtKB/Swiss-Prot
  ENST00000566102.1 UniProtKB/TrEMBL
  ENST00000570206 ENTREZGENE, UniProtKB/TrEMBL
  ENST00000570206.2 UniProtKB/Swiss-Prot
  ENST00000685868 ENTREZGENE
  ENST00000685868.1 UniProtKB/Swiss-Prot
  ENST00000690502.1 UniProtKB/TrEMBL
Gene3D-CATH Classic Zinc Finger UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
GTEx ENSG00000103449 GTEx
HGNC ID HGNC:10524 ENTREZGENE
Human Proteome Map SALL1 Human Proteome Map
InterPro Znf_C2H2_sf UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  Znf_C2H2_type UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
KEGG Report hsa:6299 UniProtKB/Swiss-Prot
NCBI Gene 6299 ENTREZGENE
OMIM 602218 OMIM
PANTHER SAL-LIKE PROTEIN UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  SAL-LIKE PROTEIN 1 UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
Pfam zf-C2H2 UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  zf-met UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
PharmGKB PA34932 PharmGKB
PROSITE ZINC_FINGER_C2H2_1 UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  ZINC_FINGER_C2H2_2 UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
SMART ZnF_C2H2 UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
Superfamily-SCOP SSF57667 UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
UniProt A0A8I5KRF8_HUMAN UniProtKB/TrEMBL
  H3BQ32_HUMAN UniProtKB/TrEMBL
  H3BSM9_HUMAN UniProtKB/TrEMBL
  Q14CE9_HUMAN UniProtKB/TrEMBL
  Q9NSC2 ENTREZGENE
  Q9P1R0 ENTREZGENE
  SALL1_HUMAN UniProtKB/Swiss-Prot
UniProt Secondary Q99881 UniProtKB/Swiss-Prot
  Q9NSC3 UniProtKB/Swiss-Prot
  Q9P1R0 UniProtKB/Swiss-Prot


Nomenclature History
Date Current Symbol Current Name Previous Symbol Previous Name Description Reference Status
2016-05-31 SALL1  spalt like transcription factor 1  SALL1  spalt-like transcription factor 1  Symbol and/or name change 5135510 APPROVED
2013-10-22 SALL1  spalt-like transcription factor 1  SALL1  sal-like 1 (Drosophila)  Symbol and/or name change 5135510 APPROVED